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The legal status of marijuana in the United States has been ever changing in the 
last few years, with many states legalizing marijuana for medicinal as well as recreational 
use—leading to increasing numbers of retail outlets. This rise in retail outlets has led to 
diversified methods of marijuana ingestion. The current study sought to understand the 
effect of methods of ingestion on frequency of use, problematic use, marijuana use 
motives, mental health, and marijuana use trajectories measured over five years. 
Additionally, the current study sought to understand the effect of contextual factors on 
method of ingestion and source of marijuana as well as transitions in methods over five 
years. Finally, this study strived to understand differences in endorsed reasons for 
choosing certain methods of ingestion. MANCOVA, Chi-square, Fisher’s Exact, and 
Ordinal logistical regression analyses were conducted on a sample of 257 participants. 
The current study found that method of ingestion was not significantly related to 
frequency of use, problematic use, use motives, mental health, nor use trajectories. This 
study did find significant relationships regarding certain contextual factors as well as 
endorsed reasons for choosing certain methods of ingestion. These results serve as a 
foundation in understanding the relationship between methods of ingestion and associated 
problems, to help support prevention and intervention strategies and mitigate negative 
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Attitudes towards marijuana in the United States have been changing over the last 
few years (Gallup, 2017). This has given rise to multiple states legalizing marijuana use 
for adult medicinal and recreational use. It is still very unclear what effect this 
legalization will have on state economics, legal systems, and public health. Rates of 
marijuana use among Americans is high, with 38.7% of young adults ages 18-25 
reporting marijuana use in the past year and 22.1% reporting use in the past month 
(Substance Abuse and Mental Health Services Administration, 2019). Rates of marijuana 
use among school-aged youth are increasing, with 16.7% of youth ages 12-17 reporting 
use in the past year, and 6.6% reporting use in the past month (Substance Abuse and 
Mental Health Services Administration, 2019). These numbers may be even higher, as 
several states have legalized marijuana for medicinal and/or recreational purposes 
following this annual publication. A body of evidence specific to recreational marijuana 
use is urgently needed to guide, prioritize, and evaluate public health and policy efforts 
(Allen et al., 2017). 
When considering marijuana use, it is important to discuss changes in methods of 
ingestion over recent years, as more methods have become accessible to users with the 
changing legalization climate. The following introduction outlines a study that examines 
current trends and associated problems related to marijuana use ingestion among young 




Significance of the Problem 
Marijuana is the most commonly used, federally illicit drug in the United States. 
Attitudes towards marijuana have become increasingly more accepting, with 64% of 
adults in favor of recreational use (Gallup, 2017). These increasingly accepting attitudes 
have given rise to legalization of marijuana for both medical and recreational use. As of 
May 2020, marijuana is legal for adult recreational use in 11 states and the District of 
Columbia, and medicinally legal in 46 states with considerable state-to-state variation in 
the regulations and laws in each state (National Conference of State Legislatures, 2020). 
The changing legal status of marijuana in the United States has led to increasing diversity 
and availability of methods of ingestion, as well as increased potency in the marijuana. 
Currently, minimal research exists on the effects that methods of marijuana 
ingestion may have on different outcomes. Looking into effects of method of ingestion 
becomes increasingly important as marijuana becomes legal for adult recreational use in 
more states. Method of marijuana ingestion has the potential to influence one’s use (e.g. 
ability to vape or use edibles in public, leading to increased frequency), and research is 
needed to understand these possible influences and guide prevention and intervention 
strategies as well as public policy. 
Marijuana is defined as a “Schedule 1” substance by the Federal Drug 
Enforcement Agency. A “Schedule 1” substance is defined as a substance with no 
accepted medical use and a substantial risk of addiction (Comprehensive Drug Abuse 
Prevention and Control Act, 1970; Federal Controlled Substance Act, 1970). Ninety-two 
million (28.6%) Americans ages 12-25 reported marijuana use in the past month. 




in 2017, similar to the percentages in 2015 and 2016. In contrast, 7.6 million (22.1%) 
young adults ages 18-25 were current users of marijuana in 2017, which is higher than 
the percentages between 2002 and 2016 (Substance Abuse and Mental Health Services 
Administration, 2018). These numbers are alarming, especially given that the legal age of 
consumption for marijuana in states with recreational use is age 21. In addition to high 
prevalence rates for adolescents, research has shown there is a high level of similarity in 
the median age of initiation for marijuana, with a median age of onset across multiple 
countries between 18 to 19 years of age (Degenhardt et al., 2008). These numbers are 
concerning for school psychologists, as many adolescents will begin using marijuana 
during high school. School psychologists are in prime positions to aid in prevention and 
intervention efforts across multiple settings for those who are starting use before high 
school graduation. 
Marijuana refers to the dried leaves, flowers, stems, and seeds harvested from the 
Cannabis sativa or Cannabis indica plant. Delta-9-tetrahydrocannabinol (THC) is the 
primary proactive ingredient in marijuana (National Institute on Drug Abuse, 2018), 
giving marijuana its mind-altering effects. Marijuana is comprised of many cannabinoids 
unique to the plant. There are several subclasses of cannabinoids that are most commonly 
studied including THC and Cannabidiol (CBD). CBD does not produce mind-altering 
effects. Researchers, including the National Institute of Health (NIH) are exploring the 
possible uses of CBD for medical treatment (National Institute on Drug Abuse, 2018b). 
While related to THC, CBD is not the focus on the current study. Marijuana can be 
consumed in many ways, including: smoking (inhaling via small pipes/joints/blunts/water 




(ingesting a more concentrated form of marijuana), oral (edible), and 
sublingually/topically (applying tinctures/creams to the skin). Methods of ingestion have 
been changing rapidly in the new legalization climate. In addition, many forms of 
marijuana are being used, including marijuana (flower), dabs (highly concentrated 
forms), edibles, and topical formulations. Marijuana dispensaries or retail stores are 
motivated to increase sales through increasing the variety of products available to 
consumers (Borodovsky, Crosier, Lee, Sargent, & Budney, 2016; Pacula, Kilmer, 
Wagenaar, Chaloupka, & Caulkins, 2014; Pacula, Powell, Heaton, & Sevigny, 2015). 
Many adverse short- and long-term consequences of marijuana use have been 
identified through research. Marijuana has been associated with cognitive (e.g., Solowij 
et al., 2002; Tapert, Schweinsburg, & Brown, 2008), psychological (e.g., Hall & Pacula, 
2003; Kalant, 2004), and injury-related factors (e.g., Hall & Pacula, 2003). Long-term, 
chronic marijuana use is associated with marijuana dependence, as well as tolerance and 
withdrawal symptoms (Budney & Hughes, 2006; Budney, Moore, Vandrey, & Hughes, 
2003; Chen, Storr, & Anthony, 2009; Copersino et al., 2006; Davis, Smith, Morphew, 
Lei, & Zhang, 2016; Hasin et al., 2015; Hasin et al., 2017; Karila et al., 2014; Katz, 
Lobel, Tetelbaum, & Raskin, 2014; Kouri & Pope, 2000; Volkow, Baler, Compton, & 
Weiss, 2014; Wen, Hockenberry, & Cummings, 2015). Regular marijuana smokers report 
pulmonary concerns (e.g., Owen, Sutter, & Albertson, 2014; Tashkin, Baldwin, Sarafian, 
Dubinett, & Roth, 2002;). Research has consistently found long-term marijuana use to be 
associated with cognitive deficits across multiple areas (see Crane, Schuster, Fusar-Poli, 
& Gonzalez, 2013 and Solowij & Battisti, 2008 for reviews), neurological changes (see 




psychosocial factors (e.g., education, psychological; Agrawal, Neale, Prescott, & 
Kendler, 2004; Fergusson & Boden, 2008; Hall, 2009; Hall & Degenhardt, 2007; 
Heitzeg, Cope, Martz, Hardee, & Zucker, 2015; Lynskey & Hall, 2000; Patton et al., 
2002; Volkow et al., 2014). These studies have failed to assess the role method of 
ingestion could have on frequency, problematic use, motives for use, and general mental 
health outcomes. 
In the last decade, research on the developmental trajectories of marijuana use has 
been increasing. This research uses group-based developmental trajectory methods to 
understand longitudinal patterns of substance use and identify subgroups of users (Kosty, 
Seeley, Farmer, Stevens, & Lewinsohn, 2016; Scholes-Balog, Hemphill, Evans-Whipp, 
Toumbourou, & Patton, 2016). This research is important as it can identify subgroups of 
youth who will escalate to regular and heavy use, and risk factors associated with these 
chronic patterns. Studies have found between three and seven developmental trajectory 
patterns of marijuana use from adolescence to adulthood, with large samples delineating 
more developmental trajectories (e.g. Homel, Thompson, & Leadbeater, 2014; 
Schulenberg et al., 2005; Terry-McElrath et al., 2017; Windle & Wiesner, 2004). Across 
these developmental trajectory studies, it was found that between 8.3-28% of those who 
initiate marijuana use escalate to monthly or more frequent use (Brook, Zhang, 
Leukefeld, & Brook, 2016; Ellickson, Martino, & Collins, 2004; Flory, Lynam, Milich, 
Leukefeld, & Clayton, 2004; Homel et al., 2014; Scalco & Colder, 2017; Scholes-Balog 
et al., 2016; Terry-McElrath et al., 2017). Many of these studies found that early, high 
level marijuana users had less favorable outcomes compared to other, lower use 




factors have been associated with chronic heavy or increasing developmental trajectories 
including: emotional dysregulation (Brook et al., 2016); aggressive and antisocial 
behavior (Passarotti, Crane, Hedeker, & Mermelstein, 2015); conduct problems 
(Ellickson, Martino et al., 2004; Flory et al., 2004; Hix-Small, Duncan, Duncan, & Okut, 
2004; Scalco & Colder, 2017; Windle & Wiesner, 2004); psychiatric disorders (Flory et 
al., 2004; Windle & Wiesner, 2004); temperament (Scalco & Colder, 2017); novelty 
seeking (Brook et al., 2016; Ellickson, Martino et al., 2004; Flory et al., 2004; Hix-Small 
et al., 2004; Passarotti et al., 2015), to name a few. None of these studies have sought to 
understand the role method of ingestion may have on subgroup membership. 
Studies have shown contextual factors (e.g., availability, price) of a substance 
have many influences on individual use as well as the population as a whole. Research 
has found substantial decreases in the price of marijuana since its legalization (Caulkins, 
Kilmer, MacCoun, Pacula, & Reuter, 2011; Hall & Lynskey, 2016). Across states where 
marijuana is legal, there is considerable variation in their laws regarding the number of 
dispensaries. Studies have found higher dispensary density to be related to higher 
likelihood of using a variety of methods of ingestion (e.g. Borodovsky et al., 2016, 2017; 
Daniulaityte et al., 2015). The allowance of home cultivation also varies by state, but 
research has found home cultivation to be associated with higher likelihood and younger 
age of onset of marijuana edible use among youth ages 14 to 18 (Borodovsky et al., 
2017). Methods of marijuana ingestion available in a location can depend on its legal 
status, and research is needed to identify emerging trends to inform timely prevention and 




et al., 2015; Gourdet, Giombi, Kosa, Wiley, & Cates, 2017; Schauer, King, Bunnell, 
Promoff, & McAfee, 2016). 
As increasing methods of marijuana ingestion become available, researchers have 
explored reasons for selecting certain methods of ingestion. These studies have found that 
marijuana users endorsed unique reasons for preferring a method of ingestion that vary 
by the specific methods studied (e.g. safer to use, stronger intoxication effect, is easily 
accessible, less side effects; Giombi, Kosa, Rains, & Cates, 2018; Lee, Crosier, 
Borodovsky, Sargent, & Budney, 2016; Loflin & Earleywine, 2014). Further research is 
necessary in this area to understand if these endorsed reasons for preferring a method of 
ingestion vary across all methods of marijuana ingestion, as well as if they vary across 
other variables including gender, age, and legal status of marijuana. 
Purpose Statement 
Building off of two social-cognitive/contextual developmental models proposed 
by Mayes and Suchman (2006; presented in chapter two), this descriptive, cross-sectional 
study sought to understand how young adult marijuana users have transitioned from one 
method of marijuana ingestion to another method, how contextual factors might play into 
their choice of method, and how reasons for using particular methods differ. In addition, 
this study examined how these factors may be associated with marijuana use and 
associated psychological problems. Primary methods of marijuana ingestion were as 
follows: joints, blunts (cigar sized joints), hand pipe, bong (water pipe), hookah, 
vaporizer (e.g. volcano, vape pen), dab rigs, edibles, and other. Primary types of 
marijuana ingested included: marijuana (flower), concentrates/dabs, edibles, and other. 




factors contributing to significant differences across outcomes, transitions, patterns, and 
reasons for using certain methods. The specific research questions and hypotheses 
addressed by this study are: 
Q1 Are certain methods of marijuana ingestion related to higher frequency of 
use and problematic use? 
 
H1 Methods of ingestion with immediate effects (i.e. smoking, vaping, 
dabbing) and potential higher potency (i.e. vaping, dabbing, oral) lead to 
increased frequency of use and problematic use. 
 
Q2 Are certain methods of ingestion related to specific motives for use? 
 
H2 Motives for marijuana use vary by primary method of ingestion, and 
methods with immediate effects and higher potency are related to coping 
motives for use. 
 
Q3 Are certain methods of ingestion associated with negative mental health 
outcomes? 
 
H3 Methods of ingestion with immediate effects (i.e. smoking, vaping, 
dabbing) and potential higher potency (i.e. vaping, dabbing, oral) lead to 
worse general mental health outcomes (e.g. anxiety and depression). 
 
Q4 Are certain methods of ingestion related to historical and current patterns 
of use in terms of frequency and transitions in methods from age of onset 
to current use? 
 
H4 Chronic and escalating marijuana use patterns are related to methods of 
ingestion with immediate effects and potential higher potency. 
Additionally, users with multiple transitions between methods of ingestion 
are related to chronic and escalation marijuana use patterns. 
 
Q5 Are primary methods of ingestion influenced by contextual factors (e.g., 
availability or awareness of methods)? 
 
H5 Primary method of ingestion is influenced by availability (e.g. legal 
status). 
 
Q6 Are endorsed reasons (e.g. safety, type of high, price) for using certain 
methods different across methods of marijuana ingestion? 
 
H6 Marijuana users endorse distinct reasons (e.g. safety, type of high, price) 






This research study has several delimitations. The participants for this study were 
self-selected among people recruited through a web forum, which can increase the 
potential for non-generalizable results. Since the survey was anonymous and no IP 
addresses were collected, it was not possible to identify repeat respondents, if any. 
Compensation was not provided for completing the survey, aside from participants 
recruited through MTurk who received a small monetary incentive. Limited or no 
compensation is a method known to discourage deception and repeat responses (Bowen, 
Daniel, Williams, & Baird, 2008). Compensation was provided to participants recruited 
through MTurk as it is required as a part of using their platform. Furthermore, the data for 
this study were self-reported; however, there is substantial support for the reliability and 
validity of self-reported data on substance use behaviors (Adair, Craddock, Miller, & 
Turner, 1995), and data obtained via web-based self-administration (Miller et al., 2002). 
Another delimitation of this study is the cross-sectional nature of the data. Longitudinal 
studies are required to understand causal relationships between methods of marijuana 
ingestion and associated problems. 
Summary 
With increasing numbers of states legalizing marijuana for medical as well as 
recreational use, a thorough understanding of methods of ingestion is necessary as 
methods of ingestion are becoming increasingly diversified and accessible. The current 
study is increasingly important, as marijuana is legalized in more states across the United 




outcomes that could arise from its legalization. This research can be used to inform 







REVIEW OF THE LITERATURE 
Prevalence and Legal Status 
In the United States, marijuana is the most commonly used, federally illicit drug. 
As of 2018, 43.5 million Americans ages 12 or older were currently users of marijuana, 
an increase of nearly 20 million since 2017 (Substance Abuse and Mental Health 
Services Administration, 2018; Substance Abuse and Mental Health Services 
Administration, 2019). Attitudes towards marijuana use have been changing over the last 
few years, with increasing numbers of individuals in favor of legalization of marijuana 
for recreational use (Gallup, 2017). This has given rise to multiple states legalizing 
marijuana use for adult medicinal and recreational use. It is still unclear how legalization 
will affect legal systems, state economies, social service systems, and public health. 
Historical Background 
Prior to 1970, marijuana was legal in the United States, and was dispensed 
through physicians and pharmacists for various medical purposes. In 1937, the Federal 
Marijuana Tax Act was passed. This act did not prohibit the distribution of marijuana. If 
one obtained a federal stamp and paid an annual tax or license fee, they were able to 
distribute medicinal marijuana. However, there was no application process and the 
stamps were unavailable. This effectively outlawed the growth and distribution of 
marijuana in the United States (Carliner, Brown, Sarvet, & Hasin, 2017; McKenna, 2014; 




Enforcement Agency defined marijuana as a “Schedule 1” substance, with the 1970 
Comprehensive Drug Abuse Prevention and Control Act, more commonly known as the 
Federal Controlled Substances Act of 1970. This act placed all controlled substances into 
five categories, or schedules related to their potential for abuse as well as recognized 
medical usefulness. A “Schedule 1” substance is defined as a substance with no accepted 
medical use and a high risk of addiction (Comprehensive Drug Abuse Prevention and 
Control Act, 1970; Federal Controlled Substance Act, 1970). This act made the use of 
marijuana illegal in the United States and implied that there was no currently accepted 
medical use for marijuana. 
Current Legal Status 
Currently as of May 2020, marijuana is legal for adult recreational use in 11 states 
and the District of Columbia, and medicinally legal in 46 states with considerable state-
to-state variation in the specific provisions of the laws (National Conference of State 
Legislatures, 2020). A list of the states and their approved laws related to marijuana can 
be found in Table 1. Marijuana is still classified as a “Schedule 1” substance and 
considered federally illegal, however, on January 4th, 2018 Attorney General Jefferson B. 
Sessions issued a memorandum regarding marijuana enforcement, rescinding previous 
nationwide guidance specific to marijuana enforcement, the Cole memorandum. Sessions 
stated that enforcement of applicable marijuana laws, regulations, and appropriations will 





Individual states approved marijuana laws as of May 2020 
State Medical 
Marijuana Law 
Limited Access Medical 
(Low THC/High CBD) 
Recreational 
Marijuana Law 
AL  X  
AK X  X 
AZ X   
AR X   
CA X  X 
CO X  X 
CT X   
DE X   
DC X  X 
FL X*   
GA  X  
HI X   
ID    
IL X  X 
IN  X  
IA  X  
KS    
KY  X  
LA X**   
ME X  X 
MD X   
MA X  X 
MI X  X 
MN X   
MS  X  
MO X* X  
MT X   
NE    
NV X  X 
NH X   
NJ X   
NM X   
NY X   
NC  X  
ND X   
OH X*   
OK X**   
OR X  X 
PA X   





Table 1, continued 
State Medical 
Marijuana Law 
Limited Access Medical 
(Low THC/High CBD) 
Recreational 
Marijuana Law 
  SC  X  
SD    
TN  X  
TX  X  
UT X* X  
VT X  X 
VA  X  
WA X  X 
WV X   
WI  X  
WY  X  
Note. * details pending; ** law not yet in effect 
As marijuana use has become legal in many states, attitudes towards marijuana 
have become increasingly more accepting. The percentage of U.S. adults in favor of legal 
recreational use has been steadily increasing with a majority of Americans in favor of 
legalization since 2013, and currently resides at 64% in favor of recreational use. This is 
a drastic change from the 12% of Americans in favor of legalization in 1969 (Gallup, 
2017). This increasingly favorable view of marijuana is also reflected on surveys 
completed by adolescents in the U.S. In the Monitoring the Future (MTF) study, 
adolescents who perceived moderate or great risk in occasional marijuana use decreased 
between 1991 and 2015, from 84.0% to 53.8% (Keyes, et al., 2016). Similar trends were 
observed in the National Survey on Drug Use and Health (NSDUH), with almost half of 
12th graders reporting no or slight perceived harm in using marijuana once or twice a 
week—an increase of almost 25% from 2006 (Azofeifa et al., 2016; Pacek, Mauro, & 
Martins, 2015; Sarvet et al., 2017). Although perceived risk in marijuana use is 




increased. However, there has been an increase in use for those ages 18 and older 
(Azofeifa et al., 2016). 
Prevalence 
Approximately 2 million (7.9%) adolescents ages 12-17 in the U.S. report using 
illicit drugs in the last month in 2017, while 8.3 million (24.2%) young adults ages 18-24 
reported illicit drug use. As stated previously, the most commonly used illicit drug among 
these age groups is marijuana, with 9.2 million (28.6%) Americans ages 12-25 reporting 
marijuana use in the past month. Approximately 1.6 million (6.5%) adolescents reported 
marijuana use in the past month in 2017; this number is similar to the percentages in 2015 
and 2016. However, 7.6 million (22.1%) young adults ages 18-25 were current users of 
marijuana in 2017; this number has increased and was higher than the percentages 
between 2002 and 2016 (Substance Abuse and Mental Health Services Administration, 
2018). In comparison, 2.5 million (9.9%) adolescents ages 12-17 drank alcohol in the last 
month, with estimates of current alcohol use among adolescents decreasing over the last 
15 years. For young adults, 19.3 million (56.3%) reported alcohol use in the last month, 
which has been relatively stable over the last 15 years (Substance Abuse and Mental 
Health Services Administration, 2018). Past month marijuana use among adolescents 
appears relatively stable, while alcohol use has been decreasing. For young adults, past 
month alcohol use has been relatively stable, however past month marijuana use has been 
increasing. These trends are concerning given that marijuana is still illegal for 
recreational use in many states across the United States, and similar to alcohol, the legal 




Little research has been completed with states that have passed recreational 
marijuana laws, and the research that does exist shows mixed results regarding increases 
in adolescent marijuana use after passing of medical and/or recreational marijuana laws. 
Carliner and colleagues (2017) reported that studies looking into the relationship between 
changes in adolescent marijuana use and passing of medical marijuana laws (MMLs) 
found there was no effect of MMLs on prevalence of adolescent use. However, another 
study found perceived harmfulness among eighth and 10th graders in Washington 
decreased 14.2% and 16.1% respectively, while marijuana use increased 2.0% and 4.1% 
post legalization, while in Colorado no differences in perceived harmfulness or past-
month use were found (Cerdá et al., 2017). Colorado has developed a committee to 
monitor concerns related to marijuana. In their most recent summary, marijuana use was 
found to have been stable among high school students since 2005, and middle school 
students since 2011. However, they found increased edible use, 27.8% to 35.6%, from 
2015 to 2017 (Retail Marijuana Public Health Advisory Committee, 2018). Additional 
trends demonstrate increases in marijuana-related emergency department visits especially 
among adolescents ages 12-17, increases in hospital admissions where patients received a 
marijuana related substance use disorder diagnosis, increases in marijuana exposure 
poison center calls, and a significant increase (tripling between 1999 and 2010) in 
marijuana metabolites in the blood of fatal accident drivers (Brady & Li, 2014; Davis, 
Mendelson et al., 2016; Wang et al., 2017; Zhu & Wu, 2016). 
Defining Marijuana and Methods of Ingestion 
Marijuana refers to the dried leaves, flowers, stems, and seeds harvested from the 




primary proactive ingredient in marijuana (National Institute on Drug Abuse, 2018). This 
ingredient is what gives marijuana its mind-altering effects, and what makes it attractive 
to users because this effect can function as a reinforcer. The reinforcing effects of THC 
are mediated by cannabinoid CB1 receptor through the activation of the mesolimbic 
dopamine system, otherwise known as the brain’s reward system which mediates a range 
of reinforcing stimuli (Cooper & Haney, 2009). The strength of the desirable or mind-
altering effect is determined by multiple factors including the dose or potency as well as 
the method of ingestion used (Budney & Borodovsky, 2017). Marijuana with higher 
levels of THC generally delivers higher levels of the desirable or mind-altering effects 
than lower potency marijuana. Therefore, marijuana users are more likely to ingest higher 
potency marijuana, because of its higher reinforcing effects. Higher potency marijuana 
can increase the chances of cannabinoid-induced behavior and physiological dependence 
(Cooper & Haney, 2009; Cooper & Haney, 2009b). Average potency for flower samples 
in the state of Colorado in 2017 was 19.6%, while for concentrate products the potency 
was on average 68.6%. Of note, there were some outlier concentrate products with 
potency at 90% or above (Orens, Light, Lewandowski, Rowberry, & Saloga, 2018). 
In addition to dose/potency, the method of marijuana ingestion contributes to the 
level of intoxication of the marijuana user (see Table 2 for a summary of the speed of and 
length of intoxication effect for each method of ingestion; Abrams et al., 2007; Corral, 
2001; Huestis, 2007; Huestis, Henningfield, & Cone, 1992; Isbell et al., 1967; 
Lemberger, Crabtree, & Rowe, 1972; Perez-Reyes et al., 1973). Marijuana can be 
administered via smoking, vaping, dabbing, orally, and sublingually/topically and these 




diversity may be partially influenced by marijuana dispensaries, or retail stores, that are 
motivated to increase sales through increasing the variety of products available to 
consumers (Borodovsky et al., 2016; Pacula et al., 2014; Pacula et al., 2015). 
Table 2 
Speed of intoxication and length of intoxication effect 
Method of Ingestion Speed of Intoxication Length of Effects 
Smoking Immediate 1 to 4 hours 
Vaping Immediate 1 to 4 hours 
Dabbing Immediate 1-2 hours strong, then 3-4 medium 
Oral Delayed Over 6 hours* 
Topical ** ** 
Note: *depending on the dose ingested; **no information available 
When smoking marijuana, one uses small pipes, joints, blunts, or water pipes to 
inhale smoke created from the burning of the flower form of marijuana. The effects of 
smoking marijuana can be felt almost immediately as the THC passes from the lungs 
directly to the blood stream, which then carries the chemical to the brain (National 
Institute on Drug Abuse, 2018). These effects last approximately 1 to 4 hours (Huestis et 
al., 1992). Smoking marijuana also produces negative or undesirable effects, including 
the delivery of known carcinogens into the body and numerous alterations in lung 
functioning (Tashkin et al., 2002). 
Marijuana can also be ingested by using electronic-cigarettes (e-cigarettes) and 
other vaping devices. These devices heat liquid (often in cartridge form) or solid 
preparations of marijuana and other substances to create a smokeless vapor with 
psychoactive compounds (e.g. nicotine, THC) that the user inhales. When vaping, the 
effects of the ingested marijuana can be felt immediately, similar to smoking marijuana, 
and it has a similar duration (Abrams et al., 2007). Vaping reduces carcinogenic toxins 




because one is inhaling the vapors, rather than the actual smoke (Van Dam & Earleywine, 
2010). Vaping has been perceived as a healthier alternative and less risky than traditional 
methods of consuming tobacco and marijuana (Camenga et al., 2015). However, as 
discussed below, recent research has shown that many patterns of lung injury have been 
reported with vaping (Henry et al., 2020).  
Dab(s) is a colloquial term that refers to a more concentrated form of marijuana, 
butane hash oil (BHO). BHO is created through the extraction of THC using butane as a 
solvent from the flower form of marijuana (Meier, 2017). This form resembles a hard, 
wax-like concentrate. BHOs can reach THC levels anywhere from 70% to 90%, 
compared to flower forms which have ranges that are nearly 10 times lower. “Dabbing” 
is the term used to describe the ingestion of BHO, while “dab” is the oil/wax placed on a 
heated glass or titanium rod (as part of a “dab rig”), typically heated with a blow torch. 
This vaporizes the substance, allowing the user to inhale the vapors (Loflin & 
Earleywine, 2014). This method of marijuana ingestion also has similar effects to 
smoking in regard to how quickly the effect is felt, however, the effects of this method 
are typically much stronger and remain stronger longer due to the higher levels of THC. 
Morean, Kong, Camenga, Cavallo, and Krishnan-Sarin (2015) found that adolescents 
who vape marijuana most often use highly potent oil, wax, or liquid preparations. 
Edibles refer to marijuana infused products that one is able to ingest orally. These 
can include products such as baked goods, drinks, and candy. The effects of this method 
of ingestion can be delayed in comparison to smoking and vaping. Often, the effects may 
not be felt for 30 minutes to an hour, because it must first be digested. This method of 




because of the delayed effect, individuals may consume more THC than intended which 
can lead to unexpected highs (Allen et al., 2017; National Institute on Drug Abuse, 2018). 
Additionally, the effects of orally ingesting marijuana can last over 6 hours depending on 
the dose ingested (Lemberger et al., 1972). These products historically have been 
frequently inaccurately labeled, with variable doses of marijuana’s proactive ingredient 
THC (Vandrey et al., 2015). Most edible products currently in the market lack 
empirically based packaging regulations, proactive ingredient levels, and safety standards 
(Benjamin & Fossler, 2016; Cao, Srisuma, Bronstein, & Hoyte, 2016). In some states 
where marijuana use is legal, there are laws in place to limit the attractiveness of edibles 
to youth and require child-resistant packaging, due to increases in edible marijuana 
overdoses among children and adolescents (Wang et al., 2016). 
Another method of administration for marijuana is sublingually or topically. This 
involves applying lotion, balm, a transdermal patch, oil, or spray to the skin. It appears 
that many of these topical methods include cannabidiol (CBD), which is a type of 
cannabinoid that tends to be non- or less-psychoactive compared to THC. One form of 
CBD (Epidiolex) was recently approved by the Food and Drug Administration (FDA) for 
medical use to treat two forms of severe epilepsy (Gottlieb, 2018; National Institute on 
Drug Abuse, 2018b). However, since this is a rapidly developing method of 
administration for marijuana, limited research is available regarding the many forms this 
topical administration can take. 
A body of evidence specific to recreational marijuana use is urgently needed to 
guide, prioritize, and evaluate public health and policy efforts (Allen et al., 2017). 




created, distributed, and accessed. These regulations can influence marijuana use age of 
onset, frequency and quantity of use, as well as the progression to problematic marijuana 
use (Budney & Borodovsky, 2017). The following review will provide the theoretical 
background for a study that will examine current trends and associated problems related 
to marijuana ingestion among young adult marijuana users. 
Theoretical Background 
As mentioned earlier, there is a high level of similarity in the median age of onset 
for marijuana use (Degenhardt et al., 2008). This suggests that there may be similar paths 
certain individuals take to their initiation of use, as well as potential development of 
substance use problems. Mayes and Suchman (2006) have proposed a developmental 
pathway to initiation of substance use among adolescents (Figure 1; added with 
permission from Dr. Mayes), as well as the progression of substance use in adolescence 
into dependence (Figure 2; added with permission from Dr. Mayes). These models 
include many mechanisms that contribute along these paths and are associated with 
greater likelihood of negative outcomes. 
In Figure 1, a set of pathways leading to the initiation of substance use in 
adolescence is shown. These pathways include individual as well as contextual factors. 
They propose that genetic factors can mediate the initiation of substance use through the 
individual development of emotional and behavioral capacities. This part of the model 
draws from Bandura’s social cognitive theory of self-regulation (Bandura, 1991). Self-
regulation and control are influenced by contextual factors such as family environment, 
peers, and school. Mayes and Suchman (2006) state that as a child develops, these prior 




positive or negative adaptations to their environment. They propose that as a child enters 
adolescence, their peers influence on substance initiation can be strongest and the 
availability of a drug can shift an adolescent away or towards drug initiation (Mayes & 
Suchman, 2006). 
 
Figure 1. Model for initiation of substance use in adolescence 
Note: From Mayes and Suchman (2006, p. 611) 
Mayes and Suchman (2006) also proposed a second developmental pathway 
model for the progression to substance dependence/addiction (see Figure 2). Similar to 
the first model, this model includes many individual factors (e.g., genetics, psychosocial) 
and some contextual factors (e.g. peers, school) on the path to substance dependence. 
Mayes and Suchman state that from initial use, there are multiple mediating factors that 




These initial mediating factors include genetic vulnerability for addiction as well as mood 
disorders, in addition to problem behaviors. From these initial mediating factors, 
contextual factors such as peer/school influence an individuals’ path to substance 
dependence. Compared to the first model, this model has a limited number of 
components that draw from the social cognitive theory. More credence could be given in 
this model to an individual’s self-development across many of the factors included, 
through their self-regulation of their motivation and actions which can contribute to the 
development of substance use disorders (Bandura, 1991; Mayes & Suchman, 2006).  
 
Figure 2. Model for the progression to substance use and dependence 
Note: From Mayes and Suchman (2006, p. 613) 
Both of these models presented by Mayes and Suchman (2006) are multilevel 
approaches that consider individual (e.g. genetic vulnerability, emotional regulation) and 




substances in adolescence, and continued drug use leading to substance dependence. In 
the first model, the present study will expand upon the contextual factors considered as 
well as include method of ingestion as a possible influence on initiation of substance use 
(see Figure 3; adapted with permission from Dr. Mayes). Mayes and Suchman (2006) 
included availability of drugs in their model, however, it is important to consider legal 
status, price, and awareness of substances. Furthermore, the availability of certain 
methods of ingestion needs to be considered as a possible mechanism that can contribute 
to initiation of substance use. In the second model, the multilevel approach considers 
individual (e.g., genetic vulnerability, problem behavior) and some contextual (e.g., 
peers, school) factors in the development of substance use disorders; however, more 
information needs to be included regarding contextual factors as well as methods of 
ingestion (McCrory & Mayes, 2015). Similar to the adaptations in the first model, this 
study will expand upon the continued influence of additional contextual factors, as well 
as explore the effects methods of ingestion may have on trajectories leading to substance 
dependence (see Figure 4; adapted with permission from Dr. Mayes). With the rise of 
legalization of marijuana across the United States, contextual factors and an 
understanding of the effects of method of marijuana ingestion become an increasingly 





Figure 3. Adapted model for the initiation of substance use in adolescence 
Note: Adapted from Mayes and Suchman (2006, p. 611) 
 
Figure 4. Adapted model for the progression to substance use and dependence 




The proposed study described in the following paragraphs will highlight the 
importance of exploring how methods of ingestion and additional contextual factors 
within these developmental pathway models influence drug use initiation and addiction. 
It is important for researchers to consider all factors that can influence these paths. By 
continuing to increase the research based on these factors, prevention and intervention 
programs can continue to be tailored and improved. 
Associations of Marijuana Use 
A multitude of adverse consequences of marijuana use have been identified in 
previous research, including both short- and long-term effects. The negative 
consequences cover a range of areas of functioning including health, education, 
psychosocial functioning, and employment status (Hall & Degenhardt, 2015; Rigucci et 
al., 2016; Volkow et al., 2014). 
Short Term Health Effects 
Marijuana use results in acute impairments in both memory and attention. These 
impairments can persist and worsen with increasing years of regular use and early 
initiation (Solowij et al., 2002; Tapert et al., 2008). Acute effects of anxiety, panic 
reaction, and psychotic symptoms have been reported, especially by first time users (Hall 
& Pacula, 2003; Kalant, 2004). Deficits in motor coordination have also been noted as an 
acute effect of marijuana use. Marijuana users have been noted to have higher rates of 
hospitalization for all causes of injury than non-users (Gerberich et al., 2003). 
Marijuana has been implicated in increasing the risk of injury or fatality while 
driving (Hall & Pacula, 2003; Hall, Renström, & Poznyak, 2016). According to Brady 




impaired driving and accidents. Marijuana use results in deficits in motor, cognitive, and 
behavioral performance that can increase accident risk (Ramaekers, Berghaus, van Laar, 
& Drummer, 2004; Rogeberg & Elvik, 2016), with the effects becoming more marked 
with increases in THC dose. Research suggests that using marijuana before driving 
increases accident risk by 2 to 3 times (Ramaekers et al., 2004). Driving simulation 
studies have found a relationship between driving performance and blood THC 
concentration (Lenné et al., 2010), with recent smoking and blood concentration levels of 
2 to 5 ng per milliliter being associated with substantial impairment (Hartman & Huestis, 
2013). The risk of injury and fatality crashes is further increased because of a link 
between marijuana use and failure to use seatbelts (Liu, Huang, & Pressley, 2016).  
New research that has been emerging has highlighted a relationship between e-
cigarette/vaping devices and acute, severe respiratory distress. Many patterns of lung 
injury, including multiple forms of pneumonia and hemorrhaging hypersensitivity 
pneumonitis, diffuse alveolar hemorrhage, acute lung injury and acute eosinophilic 
pneumonia, organizing pneumonia, lipoid pneumonia, as well aa giant cell interstitial 
pneumonia, have been associated with vaping (Henry et al., 2020). The Centers for 
Disease Control and Prevention (CDC; 2020) has termed the syndrome e-cigarette, or 
vaping, product use-associated lung injury (EVALI). As of February 18, 2020, the CDC 
reported a total of 2,807 patients hospitalized with EVALI, with reports from all 50 states 
and the District of Columbia. Sixty-eight deaths have been confirmed across the United 
States as a result of EVALI (CDC, 2020). The majority (82%) of individuals who vaped 
and experienced EVALI reported having used products with THC or CBD, with 33% of 




patients reported using nicotine-containing products, with 14% reporting exclusive use of 
nicotine-containing products (CDC, 2020). 
Long Term Health Effects of Chronic Use 
One of the most well-known long-term effects of chronic marijuana use is 
Cannabis Use Disorder (CUD; formerly called Marijuana Abuse/Dependence). CUD is 
characterized by biopsychosocial impairments that increase in severity with frequent and 
heavy use (Hasin et al., 2013; Hasin et al., 2015; Sherva et al., 2016). Rates of CUD have 
increased over the last decade, especially in states with legalized marijuana (Hasin et al., 
2015; Hasin et al., 2017; Wen et al., 2015). Studies have reported that the risk of 
dependence is around 9% for those who have ever used marijuana, with increases to one 
in six for those who initiate use in adolescence (Anthony, Warner, & Kessler, 1994; Chen 
et al., 2009; King & Chassin, 2007; Lopez-Quintero et al., 2011; Volkow et al., 2014), 
and 25 to 50% for daily users (Hall & Degenhardt, 2009; Hall & Pacula, 2003; van der 
Pol et al., 2013). Chen and colleagues (2009) reported that those who initiate in 
adolescence are 2 to 4 times more likely to report symptoms of marijuana dependence 
within 2 years after initiation. Additional research found that 19.5% of lifetime marijuana 
users meet criteria for DSM-5 CUD, with 23% who were symptomatically severe, of 
these 48% were not functioning in major roles (e.g., work; Hasin et al., 2016). Multiple 
studies have shown that higher potency products can increase the probability of 
experiencing desirable effects from marijuana use. Higher potency products (e.g., 
concentrates) paired with methods that can be considered less harmful (e.g. less 




(Agrawal et al., 2006; Cooper & Haney, 2009; Fergusson, Horwood, Lynskey, & 
Madden, 2003). 
Tolerance and withdrawal symptoms are commonly reported with long term use. 
Marijuana users can develop a tolerance to the effects of THC, which leads to increased 
dose, frequency, or potency to reach the same desired effect (Maldonado, 2002). 
Withdrawal symptoms typically occur when one stops or cuts back on their marijuana use 
(Budney & Hughes, 2006; Kouri & Pope, 2000) and can be reversed with the ingestion of 
THC (Budney & Hughes, 2006; Budney, Vandrey, Hughes, Thostenson, & Bursac, 2008; 
Lichtman, Fisher, & Martin, 2001). Typical withdrawal symptoms include sleep 
difficulty, restlessness, physical symptoms such as shakiness or tremors, sweating, fever, 
chills, and headaches, decreased mood and appetite, in addition to increased irritability, 
anger, anxiety or nervousness, and depression (Budney & Hughes, 2006; Karila et al., 
2014; Katz et al., 2014; Kouri & Pope, 2000). Individuals who experience withdrawal 
symptoms typically experience a functional impairment of normal daily activities (Allsop 
et al., 2012; Davis, Smith et al., 2016; Karila et al., 2014; Katz et al., 2014;). Typically, 
withdrawal symptoms occur 1 to 2 days after an individual has stopped heavy use. They 
are most intense during the first week of abstinence, with effects that can persist as long 
as a month (Budney et al., 2003; Copersino et al., 2006; Davis, Smith et al., 2016; 
Elkashef et al., 2008; Hall et al., 2016; Kouri & Pope, 2000; Milin, Manion, Dare, & 
Walker, 2008). 
Marijuana use has also been found to have long-term effects on physical health. 
Additional research on the health effects of marijuana has found that regular marijuana 




2002; see Tetrault et al., 2007 for a review). It has been reported that immunological 
competence is also impaired by marijuana use, increasing risks for respiratory infections 
and pneumonia (Owen et al., 2014; Tashkin et al., 2002). Marijuana use has been 
associated with inflammation of airways, airway resistance, and lung hyperinflation in 
regular heavy users, but not infrequent users (Pletcher, et al., 2012; Tashkin, 2013). 
Cancer risk for marijuana users has been implicated, but research has not 
consistently reported an association. It is possible that marijuana use may cause cancers 
due to containing the same carcinogen, at higher levels, as tobacco smoke (Callaghan, 
Allebeck, & Sidorchuk, 2014; Hashibe et al., 2005), however evidence has suggested risk 
of cancer is lower with marijuana than with tobacco (Hashibe et al., 2006). Marijuana has 
also been implicated with cardiovascular risks, with research showing association with 
vascular conditions that increase the risk of myocardial infarction (Mittleman, Lewis, 
Maclure, Sherwood, & Muller, 2001), stroke, and transient ischemic attacks during 
marijuana intoxication (Thomas, Kloner, & Rezkalla, 2014) due to THC producing a 
dose-related increase in heart rate (Jones, 2002). 
Research has consistently shown deficits in verbal learning, memory, and 
attention in regular marijuana users (Solowij et al., 2002; Solowij & Pesa, 2012; see 
Crane et al., 2013 and Solowij & Battisti, 2008 for reviews). Marijuana has been shown 
to impair the neural connectivity of the precuneus, which is involved in functions such as 
alertness and awareness, and the fimbria, which is an area in the hippocampus important 
in learning and memory (see Broyd et al., 2016 for a review; Zalesky et al., 2012). It has 
been found to affect certain subcortical networks, specifically those that process habits 




reduced functional connectivity in the prefrontal networks responsible for executive 
functioning (e.g. inhibitory control and working memory; Renard et al., 2016). Renard 
and colleagues (2016) found chronic marijuana use altered the prefrontal cortex (PFC) 
structure and impaired cortical synaptic plasticity in the hippocampus-PFC circuit, and 
imaging studies have shown deceased activity in the prefrontal regions and reduced 
volumes in the hippocampus (Batalla et al., 2013). Furthermore, past work has found an 
association between frequent use of marijuana from adolescence into adulthood and 
significant declines in IQ, with effect sizes ranging from -.11 to -.038 (a loss equivalent 
up to approximately 6 IQ points; Meier et al., 2012). 
Research has also consistently shown that deficits in cognitive functioning and 
changes to brain structures are related to the duration and frequency of marijuana use (a 
dose-dependent response), the age of initiation, and the estimated cumulative dose of 
THC (Solowij et al., 2002; Solowij & Pesa, 2012; see Crane et al., 2013 and Solowij & 
Battisti, 2008 for reviews). In other words, the negative effect of marijuana on cognition 
and functional connectivity of the brain is increasingly prominent if use starts in 
adolescence and is regular or chronic and heavy (Zalesky et al., 2012). These findings are 
consistent with preclinical findings that indicate the cannabinoid systems play a 
prominent role in synapse formation during brain development and can be impaired with 
exposure to marijuana in adolescence (Gaffuri, Ladarre, & Lenkei, 2012). 
Psychosocial Effects of Marijuana Use 
Marijuana has been associated with poor educational attainment among school 
children (see Lynskey & Hall, 2000 for a review; Degenhardt, Hall, & Lynskey, 2001; 




et al., 2014). Early marijuana use has been associated with impaired performance in 
school, increased risk of dropping out of school, in addition to lower chances of pursuing 
post-secondary training (Bray, Zarkin, Ringwalt, & Qi, 2000; Horwood et al., 2010; 
Lynskey & Hall, 2000; Meier et al., 2012). Ellickson, Bui, Bell, and McGuigan (1998) 
found that marijuana use before the age of 15 was related to dropping out of high school, 
even after adjusting for confounding variables. As noted earlier, marijuana use beginning 
in adolescence is related to cognitive impairments (Meier et al., 2012), which can lead to 
failure to learn in school and interfere with the capacity to achieve educational goals. 
This leads to poor grades and possibly dropping out of school (Lynskey & Hall, 2000). 
Across multiple cross-sectional (Compton, Gfroerer, Conway, & Finger, 2014; 
Cunradi, Ames, & Xiao, 2014; De Simone, 2002) and longitudinal studies (Fergusson & 
Boden, 2008) that have adjusted for sociodemographic characteristics, marijuana use has 
been associated with negative employment outcomes. Specifically, marijuana use has 
been associated with future job loss (Compton et al., 2014), reduced likelihood of 
employment (Cunradi et al., 2014), and difficulties at work (Degenhardt et al., 2001). 
Fergusson and Boden (2008) found that increasing levels of marijuana use from ages 14 
to 21 was related to higher unemployment at data points between ages 21 and 25. Heavy 
marijuana use has also been associated with lower income, and greater need for 
socioeconomic assistance (Brook, Lee, Finch, Seltzer, & Brook, 2013; Fergusson & 
Boden, 2008). 
Research conducted in a number of countries has shown that early marijuana use 
can predict increased risk of using other illicit drugs, even though not all who use 




Swift et al., 2012). Swift and colleagues (2012) found those who reported weekly and 
daily marijuana use were consistently reporting amphetamine, cocaine, and ecstasy use at 
two to three times the rate of those who reported occasional use of marijuana. The order 
in which the illicit drugs are used aligns with the prevalence of different types of illicit 
drugs used in the adult population of the country (Degenhardt et al., 2010). Twin studies 
have shown that a twin who uses marijuana before age 17 is more likely to have used 
sedatives, hallucinogens, stimulants, and opioids than a twin who did not use marijuana 
(Ellickson, D’Amico, Collins, & Klein, 2005; Ellickson, Tucker et al., 2004; Lynskey et 
al., 2003). 
Marijuana Use and Mental Health 
Long-term research on adolescent marijuana users has shown they report greater 
negative emotionality than healthy controls between the ages of 13 and 23 (Heitzeg et al., 
2015). Moreover, this negative emotionality remained elevated rather than decreasing 
with age as in the healthy controls. Chronic marijuana use has also been associated with 
both blunted and hyperactive stress responses (Cuttler et al., 2017). Cuttler et al. (2017) 
found healthy controls had increases in cortisol levels under a stress-provoking situation, 
however, the same increase was not found in active marijuana users. 
Regular marijuana use has been associated with increased risk of anxiety and 
depression (Patton et al., 2002), although the literature is mixed, as well as lower 
satisfaction with life (Brook et al., 2013; Fergusson & Boden, 2008). Moore et al. (2007) 
completed a meta-analysis on the relationship between marijuana use, anxiety, and 
depression. Outcomes across included studies were not consistent, with marijuana 




confounding variables. Research has found that adolescents undergoing treatment for 
withdrawal symptoms from marijuana had at least one comorbid diagnosis of anxiety or 
depression and greater marijuana use was associated with increased depressive and 
anxiety-like symptoms (Dorard, Berthoz, Phan, Corcos, & Bungener, 2008). Genetic 
studies have found CUD shared genetic risk with depression (Carey et al., 2016; Sherva 
et al., 2016). Additional genetic research suggests common causes underlying the 
comorbidity between CUD and depression (Hodgson et al., 2016), or a causal effect of 
CUD on depression (Smolkina et al., 2017). Henquet, Krabbendam, de Graaf, ten Have, 
and van Os (2006) found marijuana use at baseline predicted increased risk of manic 
symptoms in patients diagnosed with bipolar disorder in a 3-year follow-up. Clinical 
studies have found individuals diagnosed with bipolar disorder who continue to use 
marijuana have increased frequencies of manic episodes and are less satisfied with their 
lives than those who do not use marijuana (Silberberg, Castle, & Koethe, 2012). 
Marijuana use has been associated with psychotic symptoms as well as psychotic 
disorders, especially among individuals with a preexisting genetic vulnerability (Brook, 
Brook, Zhang, Cohen, & Whiteman, 2002; Caspi et al., 2005; Charilaou et al., 2017; 
Hall, 2009; Volkow et al., 2014). A meta-analysis of longitudinal research looking into 
the relationship between psychotic symptoms and marijuana found that the relationship 
between psychotic symptoms or psychotic disorders among those who had used 
marijuana was higher in regular users, with a dose-response relationship between 
frequency of use and risk for developing psychotic symptoms or a psychotic disorder 
(Moore et al., 2007). Another meta-analysis showed that individuals who were at high 




positive psychotic symptoms (e.g., unusual thought content, suspiciousness; Carney, 
Cotter, Firth, Bradshaw, & Yung, 2017). Heavier marijuana use, greater drug potency, 
and early initiation have all been found to negatively affect the disease trajectory through 
earlier than average age of first-episode psychosis (i.e., by advancing the time of a first 
psychotic episode by 2 to 6 years; Di Forti et al., 2013; Large, Sharma, Compton, Slade, 
& Nielssen, 2011). 
Research into the associations between self-harm, suicidal ideation, suicide 
attempts, and marijuana use has been inconclusive. More than weekly marijuana use was 
associated with increased likelihood of reporting suicidal ideation, but only in males (van 
Ours, Williams, Fergusson, & Horwood, 2012). In contrast, another study found that 
marijuana was associated with self-harm only in females (Patton et al., 1997). 
Motives for Use 
Negative outcomes related to marijuana use often vary person to person. 
Similarly, marijuana users often report a range of reasons, or motives, for using 
marijuana. Past studies have shown that certain motives are related to increased risks 
across many psychosocial factors. It is possible that motives for using may also differ 
based on the method of ingestion used. Much of the past work on motives for using 
marijuana has focused on delineating these motives, as well as how they vary both 
between and within individuals (Bonn-Miller, Zvolensky, & Bernstein, 2007). Some of 
the more common motives found to be significant in research are coping, 
experimentation, and social motives. Studies have found that coping, enhancement, 
social, enjoyment, boredom, altered perception, relative low-risk, sleep/rest, and 




(Bonn-Miller et al., 2007; Lee, Neighbors, Hendershot, & Grossbard, 2009). A study by 
Bonn-Miller and Zvolensky (2009) found associations between marijuana dependence 
and higher motivation to use marijuana for multiple reasons including enhancement, 
conformity, and coping. A more recent study found greater endorsement of using 
marijuana to cope to be associated with greater problematic use (Phillips, Lalonde, 
Phillips, & Schneider, 2017). Lee and colleagues (2009) also found experimentation and 
availability motives for use to be associated with less use. Davis, Arterberry, Bonar, 
Bohnert, and Walton (2018) found conformity and passion motives to be associated with 
greater frequency of use. This finding is unique in that it highlights the importance of 
assessing passion for marijuana use, as obsessive passion has been shown to predict 
frequency of use and related consequences. These studies evaluated the relationship 
between marijuana use motives, frequencies of use, and problematic use; however, none 
of these studies addressed the relationship of use motives with methods of ingestion. 
Undoubtedly, marijuana has been associated with a plethora of negative effects 
and outcomes both in the short- and long-term. Unfortunately, a major limitation of these 
studies is that chronic heavy or regular marijuana users differ from non-users in a variety 
of ways that are reflected through baseline differences (e.g., more likely to use alcohol, 
differ in risk-taking behaviors; Hall, 2015). So, while it has been noted marijuana is 
associated with many negative outcomes, causal evidence is lacking. Furthermore, a 
number of the negative outcomes mentioned above noted increased negative effects as 
the frequency of marijuana increased but have failed to assess the role method of 
ingestion may have had in those increased negative effects (e.g. Agrawal et al., 2006; 




Additional research is needed to see if methods of marijuana ingestion are associated 
with frequency of use, problematic use, motives for use, and general mental health 
ratings, in the current legalization climate with increasingly diversified methods of 
ingestion. 
Patterns/Trajectories of Marijuana Use 
Understanding the factors involved in long-term marijuana use can help delineate 
youth who will initiate, experiment, and remain stable low users or phase out of 
substance use altogether versus the small proportion of youth who will escalate to regular 
and heavy use. This research is important as it can lead to targeted prevention and 
intervention strategies for substance use disorders (Scalco & Colder, 2017). Research 
using group-based developmental trajectory methods has shown considerable 
heterogeneity within populations in longitudinal patterns of substance use, where 
subgroups can be defined through patterns in timing, magnitude, and duration of risk 
(Kosty et al., 2016; Scholes-Balog et al., 2016). These developmental trajectories are able 
to identify the subgroups of youth who increase the frequency of their use over time and 
escalate from more infrequent users to regular and chronic, heavy users. This information 
can be used to provide targets for direct and intense prevention and intervention efforts. 
Studies historically have found between three and seven developmental trajectory 
patterns of marijuana use from adolescence to adulthood (e.g. Homel et al., 2014; 
Schulenberg et al., 2005; Terry-McElrath et al., 2017; Windle & Wiesner, 2004). 
Previous research on developmental trajectories will be discussed to outline past findings 
and the associated risk factors to relate this work to changes in methods of ingestion. 




age and number of participants, years followed, number of classes, and class descriptions, 
can be found in Table 3. 
Developmental Trajectories 
Three developmental trajectory groups have been identified in numerous studies. 
Non-users, early users, and late onset users were identified in two separate studies 
following participants from adolescents until young adulthood (Flory et al., 2004; 
Scholes-Balog et al., 2016). In another study, trajectory groups of abstainers, occasional 
users, and frequent users were identified in a cohort followed from adolescence until 
young adulthood (Homel et al., 2014). Kosty and colleagues (2016) followed participants 
from adolescence until adulthood and classified participants into the classes of persistent 
increasing risk, maturing out with increasing risk then decreasing risk, and stable low 
risk. 
Two studies have identified four trajectory groups. Following participants from 
early adolescence until young adulthood, Scalco and Colder (2017) identified classes 
consisting of: non-users, experimenters, early initiator-increasing users, and sharp 
increasing users. Four developmental trajectories were also found following a sample of 
students from early adolescence until adulthood. The trajectories were early onset with 
heavy use that decreased with age, light but persistent use, steady increase from age 13 to 
23, and occasional use (Ellickson, Martino et al., 2004). 
Five developmental trajectories have been identified by three separate studies. 
Passarotti and colleagues (2015) followed adolescents over 6 years. They revealed non-
users, three trajectory classes of non-escalating users (low users, medium users, and high 




from early adolescence to early midlife found the trajectory groups of chronic 
users/decreasers, quitters, increasing users, chronic occasional users, and 
nonusers/experimenters (Zhang, Brook, Leukefeld, & Brook, 2016). Windle and Wiesner 
(2004) followed high school students through early adulthood, and found five 
developmental trajectory groups – high chronic, increasers, decreasers, experimental 
users, and abstainers. 
Additionally, three studies have identified six to seven trajectory classes. 
Participants followed from mean age 14 until mean age 43 by Brook and colleagues 
(2016) resulted in six developmental trajectory classes of marijuana use: chronic/heavy 
users, increasing users, chronic/occasional users, decreasers, quitters, and 
nonusers/experimenters. Using data from the Monitoring the Future Study, Schulenberg 
et al. (2005) examined high school seniors through age 24 to understand developmental 
trajectories. In this study, six trajectory groups were delineated: chronic, decreased, 
increased, fling, rare, and abstain. Finally, Terry-McElrath and colleagues (2017) 
followed participants from high school to age 50 and found seven developmental 
trajectories of marijuana use. The trajectories were: non-users, two shorter-term use 
classes, and four classes with longer-term moderate or heavy use. 
Across these studies, 5-28% of those who initiated marijuana use escalated to 
monthly or more frequent use (e.g., Schulenberg et al., 2005; Terry-McElrath et al., 
2017). Furthermore, many of these studies found that early, high level marijuana users 
had less favorable outcomes compared to other, lower use trajectory groups (e.g. 
Ellickson, Martino et al., 2004; Homel et al., 2014; Terry-McElrath et al., 2017). The 




early initiation is followed by divergent trajectories over time, meaning the relationship 
between initiation and escalation is complex (Scalco & Colder, 2017). An understanding 
of the risk factors associated with escalating heavy use is important to identify 





Summary of studies regarding patterns/trajectories of marijuana use 




Class Descriptions (Percentage of 
participants in each class) 
Flory et al., 
2004 
481 Ages 11-12 
until 20-22 
3 Non-users (*) 
Early Onset (*) 
Late Onset (*) 
Homel et al., 
2014 
632 Ages 15 
until 25 
3 Abstainers (31%) 
Occasional Users (44%) 
Frequent Users (25%) 
Kosty et al., 
2016 
816 Ages 14 
until 30 
3 Stable Low Risk (84%) 
Maturing Out (9%) 
Persistent Increasing Risk (7%) 
Scholes-Balog 
et al., 2016 
852 Ages 12 
until 21 
3 Abstainers (62%) 
Early Onset Users (11%) 
Late Onset Occasional Users (27%) 
Ellickson, 
Martino et al., 
2004 
5,833 Age 13 
until 29 
4 Occasional Light Users (53%) 
Early Light Users (5%) 
Stable Light Users (17%) 
Steady Increasers (25%) 
Scalco & 
Colder, 2017 
755 Ages 11 
until 18 
4 Non-user (33%) 
Experimenter (38%) 
Early Initiator-Increasing (14%) 
Sharp Increasing (15%) 
Passarotti et al., 
2015 
1,204 Ages 15 
until 22 
5 Never/Non-Users (22%) 
Low Users (29%) 
Medium Users (24%) 
High Users (8%) 
Escalating Users (17%) 
Windle & 
Wiesner, 2004 
1,205 Ages 15 
until 23 
5 Abstainers (82%) 
Experimental Users (9%) 
Increasers (4%) 
Decreasers (3%) 
High Chronics (2%) 
Zhang et al., 
2016 
548 Ages 1-10 
until mean 
age 43 
5 Nonusers/Experimenters (40%) 
Chronic Occasional Users (26%) 
Increasing Users (7%) 
Quitters (19%) 
Chronic Users/Decreasers (8%) 
Brook et al., 
2016 
548 Ages 14 
until 43 
6 Nonusers/Experimenters (35%) 
Quitters (22%) 
Decreasers (14%) 
Chronic/Occasional Users (20%) 
Increasing Users (5%) 





Table 3, continued 
 




Class Descriptions (Percentage of 
participants in each class) 
Schulenberg et 
al., 2005 
19,952 Ages 18 
until age 
24 







et al., 2017 
9,831 Ages 18 
to 50 
7 Non-Users (44%) 
Early YA** Moderate Users (22%) 
YA** Moderate Users (12%) 
Persistent Moderate Users (6%) 
Early YA** Heavy Users (6%) 
YA** Heavy Users (5%) 
Persistent Heavy Users (5%) 
Note: * not reported by the study; ** YA = Young Adult 
Risk Factors Associated with Chronic/Heavy  
Use Developmental Trajectories 
Research has shown certain risk factors are associated with chronic heavy or 
increasing marijuana use from adolescence to young adulthood. Chronic heavy and 
increasing marijuana users were distinguished from lower or non-users by demographic 
variables such as: male gender (e.g. Ellickson, Martino et al., 2004; Juon, Fothergill, 
Green, Doherty, & Ensminger, 2011; Silins et al., 2013; Terry-McElrath et al., 2017), 
pubertal development at baseline (Scalco & Colder, 2017), low religious commitment 
(Jackson, Sher, & Schulenberg, 2008; Silins et al., 2013; Terry-McElrath et al., 2017), 
race/ethnicity with inconsistent results (Ellickson, Martino et al., 2004; Silins et al., 
2013), and marriage (Schulenberg et al., 2015; Staff et al., 2010). These distinguishing 
variables also included factors related to individual as well as parental levels of education 
including adolescent school performance or commitment (Flory et al., 2004; Passarotti et 
al., 2015), not attending college (Nelson, Van Ryzin, & Dishion, 2015; Passarotti et al., 




2015; Terry-McElrath et al., 2017). Peer influence, substance use, and delinquency were 
also associated with chronic heavy and increasing trajectories (Ellickson, Martino et al., 
2004; Flory et al., 2004; Hix-Small et al., 2004; Passarotti et al., 2015; Scalco & Colder, 
2017). Finally, a number of psychological and personality factors have been identified in 
more heavy users, including emotional dysregulation (Brook et al., 2016), aggressive and 
antisocial behavior (Passarotti et al., 2015), conduct problems (Ellickson, Martino et al., 
2004; Flory et al., 2004; Hix-Small et al., 2004; Scalco & Colder, 2017; Windle & 
Wiesner, 2004), psychiatric disorders (Flory et al., 2004; Windle & Wiesner, 2004), 
temperament (Scalco & Colder, 2017), novelty seeking (Brook et al., 2016; Ellickson, 
Martino et al., 2004; Flory et al., 2004; Hix-Small et al., 2004; Passarotti et al., 2015), 
and co-morbid substance use (Brook et al., 2016; Jackson et al., 2008; Passarotti et al., 
2015; Silins et al., 2013; Terry-McElrath et al., 2017). Many important risk factors have 
been identified, however, no studies to date have sought to understand if method of 
ingestion could be a risk factor for chronic heavy or escalating use. 
Research on the longitudinal course or pattern of marijuana use is an area that is 
currently growing. With increasing social acceptance and legalization of marijuana in the 
United States today, it is likely that the age of onset could become increasingly younger 
and these developmental trajectories could change. Continued understanding of patterns 
of marijuana use during adolescence and emerging adulthood is needed, specifically in 
terms of why some abstain, maintain low levels, escalate their use over time, or 
decrease/quit their use altogether. Risk factors for heavy use developmental trajectories 
have been discovered in the research, however, there are still risk factors that need to be 




a critical area to research as it is quickly changing. Information about patterns of 
marijuana use frequency, quantity, and method of ingestion, particularly among emerging 
adults, is needed to improve understanding of health consequences related to marijuana 
use and for public health planning (Tucker, Ellickson, Orlando, Martino, & Klein, 2005). 
In addition to increasing the understanding of the frequency of marijuana use in 
developmental trajectories it will be important to also consider transitions in method of 
ingestion. Often times we think about how individuals move across substances, starting 
with tobacco and alcohol, and perhaps to illicit drugs. However, the transitions within a 
specific type of drug have been studied less, specifically for illicit drugs and methods of 
use within a specific type of drug. The developmental trajectory research presented 
earlier assessed marijuana use from early adolescence until adulthood. In that time, many 
transitions in methods of ingestion could occur for various reasons and coincide with 
increases in the frequency of marijuana use. Some of these reasons could be related to 
availability, perceptions, as well as context. This information is important for increasing 
knowledge about marijuana use, especially as the legal status of marijuana in the United 
States is shifting and the availability of methods is increasing. 
Contextual Factors 
The availability, or ease/difficulty of accessing a substance, has many influences 
on individuals as well as the population as a whole. Availability of a substance can be 
affected by many different factors, including the monetary price or cost of the product as 
well as the amount of effort and time required to obtain the product. The increasing 
number of states that have legalized medicinal and recreational marijuana has likely 




one dispensary per square mile was cross-sectionally associated with a 6.8% increase in 
marijuana hospitalizations with a marijuana abuse/dependence code. This study is one 
example of how contextual factors (e.g. price, availability) can affect marijuana use. 
Additional studies in key contextual areas are outlined below. 
Monetary Price 
The changing legal status of marijuana in the United States has had an effect on 
the monetary price of marijuana. Research has shown that there have been substantial 
decreases in the price of marijuana when compared to its pre-legalization cost (Caulkins 
et al., 2011; Hall & Lynskey, 2016). Past research on alcohol and tobacco has shown a 
clear relationship between the price of the product and frequency of use across 
populations (Chaloupka, Cummings, Morley, & Horan, 2002; Chaloupka, Straif, & Leon, 
2011; Pacula et al., 2014). Since each state is responsible for drafting laws and 
regulations regarding marijuana, tax rates, manufacturing sales, and purchase levels will 
need to be considered individually for each state (Budney & Borodovsky, 2017). The 
aforementioned factors will need to be regulated while also considering how black 
markets related to marijuana will change in response to these factors (Caulkins et al., 
2011). 
Ease of Access 
The regulations that have been passed by states regarding marijuana use are 
highly variable, with many different provisions. Currently, some states provide access to 
marijuana through retail stores or medical dispensaries. Due to the variations in 
marijuana regulation laws, some states permit a limited number of medical dispensaries 




numbers of outlets available to purchase marijuana can lead to higher availability through 
lowering consumer travel time and cost of transportation (Budney & Borodovsky, 2017). 
Borodovsky and colleagues (2016, 2017) found longer periods of marijuana legalization 
and higher marijuana outlet (recreational and medical) density were related to higher 
likelihood of lifetime vaping and edible use for youth ages 14 to 18 in states with legal 
recreational marijuana use as well as adults in states with legal medicinal marijuana use. 
In fact, they found that higher marijuana outlet density was associated with younger age 
of onset of vaping in addition to doubling the likelihood of youth trying vaping and 
tripling the likelihood of trying edibles. Of 634 adults who were past-year marijuana 
users in Colorado, 70% tried a new marijuana or hashish product during the first year that 
recreational marijuana was legal in Colorado (Allen et al., 2017). In this study, trying 
new products the year after recreational marijuana was legalized in Colorado was 
associated with greater odds of experiencing an unexpected high after controlling for 
many variables including current use and amount of marijuana consumed in the past 
month (Allen et al., 2017). The CDC reported that 50% of EVALI patients provided data 
on the product source. Sixteen percent of the individuals reported acquiring products only 
from commercial sources (recreational and/or medical dispensaries, vape or smoke shops, 
stores, and pop-up shops), while 78% reported obtaining products from informal sources 
(family/friends, dealers, online, or other sources). Six percent of individuals reported 
acquiring products from both commercial and informal sources (Centers for Disease 





Another way in which regulations can affect these factors is through provisions 
that allow individuals to grow marijuana (“home cultivation”). Home cultivation provides 
easier access to marijuana. While there may be policies regulating home cultivation in 
states where marijuana is legal, home cultivation presents many challenges in terms of 
enforcement as well as preventing excessive growth of marijuana (Budney & 
Borodovsky, 2017). Research on medical marijuana laws and their effect has found that 
home cultivation was predictive of last month as well as heavy use (Pacula et al., 2015). 
Borodovsky and colleagues (2017) also found home cultivation to be associated with 
higher likelihood and younger age of onset of marijuana edible use among youth ages 14 
to 18. Among persons ages 12 and older, higher percentages of participants were 
reporting marijuana was easier to access. Participants also reported more frequently 
buying and growing marijuana versus getting it for free and sharing it (Azofeifa et al., 
2016). 
Awareness 
In the last few years, research on the prevalence of marijuana information on 
social media has been increasing. Studies analyzing tweets on Twitter have found 
significantly greater numbers of tweets regarding edibles and dabs in states that allow 
recreational and/or medical use of marijuana (Daniulaityte et al., 2015; Lamy et al., 2016; 
Lamy et al., 2018), as well as pro-marijuana (i.e. plans to use, health benefits, 
legalization) tweets among those younger than 20 years of age (Cavazos-Rehg et al., 
2015). Specifically, Lamy and colleagues (2018) found tweets regarding dabs to be 




versus states where it is illegal. Furthermore, they found the tweets regarding edibles to 
be generally positive themed, while the tweets regarding dabs promoted it as a safe 
method. Cavazos-Rehg, Zewdie, Krauss, and Sowles (2018) further analyzed tweets 
regarding edibles and found that nearly half normalized marijuana use or plans to 
consume. Individuals who promoted edibles were more likely to be between the ages of 
17 and 24 years old. Another study (Cavazos-Rehg et al., 2016) that analyzed tweets 
about high-potency marijuana found that common themes included discussions 
surrounding intense high and/or extreme effects (i.e. physiological and psychological) 
from dabbing (22%) as well as excessive/heavy dabbing (15%). Several studies have 
examined YouTube videos on edibles and dabs. Overall, they demonstrated that such 
information was easily accessible, and many videos provided educational information 
(e.g. instructions, warnings; Krauss et al., 2015; Krauss, Sowles, Stelzer-Monahan, 
Bierut, & Cavazos-Rehg, 2017). A study regarding marijuana related posts on Reddit 
found the volume of posts on dabs increased significantly from 2010-2016 (Meacham, 
Paul, & Ramo, 2018). These studies highlight a number of important points, including 
how easy it is to access information on methods of marijuana ingestion, how younger 
individuals tend to broadcast their use of certain methods through “posts” on social 
media, as well as changing trends in volumes of posts related to certain methods of 
ingestion. 
As social acceptability and legalization of marijuana are shifting, availability and 
awareness of different methods of ingestion are new areas of research that need to be 
explored. Methods of marijuana ingestion in states where marijuana is legal are different 




regarding certain methods of ingestion have been changing over the years (Meacham et 
al., 2018). Research is needed to identify emerging trends due to changing marijuana 
legalization policies, to inform timely prevention and policy measures, and minimize 
potential dangers of certain methods of use to consumers (Daniulaityte et al., 2015; 
Gourdet et al., 2017; Schauer et al., 2016). 
Reasons for Using Specific Methods of Ingestion 
As increasing methods of marijuana ingestion become available, the reasons why 
specific methods of ingestion are used or not used is becoming an increasingly important 
question. These reasons could potentially effect population level statistics including age 
of onset, frequency, and quantity of use. More evidence is necessary to guide regulatory 
processes in states to determine how products can be created, distributed, and accessed to 
ensure safety in regards new methods of use (Budney & Borodovsky, 2017). 
In focus groups (N = 62) conducted in Denver, Colorado, and Seattle, 
Washington, Giombi and colleagues (2018) found that edible marijuana users endorsed 
many reasons for liking edibles, including being smoke-free, more discreet, longer high, 
less intense high, and enjoying the taste. Participants in this study also endorsed many 
reasons for disliking edibles, many of which were related to edibles being unpredictable 
and variable in potency. Loflin and Earleywine (2014) assessed reasons why 357 
participants ages 18 to 71 preferred dabs to flower methods of marijuana ingestion. They 
found that participants endorsed some reasons (e.g., different kind of high, stronger 
intoxication effect, effects last longer, and fewer “hits” needed) more than others (safer to 
use, less side effects, and price). This finding is interesting as it found that some 




This could mean that individuals who use dabs might be at a higher risk for substance use 
disorders as reasons for using this method are related to a stronger intoxication effect. 
Another study by Lee and colleagues (2016) assessed 2910 participant’s perceptions of 
effects for those who prefer smoking or vaping marijuana. Those who smoke reported 
different reasons compared to those who vape. Specifically, participants who preferred 
vaping over smoking endorsed reasons of healthier, better tasting, produced better effects, 
and more satisfying (Lee et al., 2016). This suggests that endorsed reasons for using a 
method of ingestion may differ depending on one’s primary motive for using marijuana 
(e.g., for social purposes, to experiment, coping). 
Methods with more positive perceptions that are also more readily available may 
influence patterns of use in the United States (Lee et al., 2016), and currently research is 
extremely limited in this area. Research regarding methods of marijuana ingestion is 
needed to identify emerging trends in this new legalization landscape, to inform timely 
prevention and policy measures, and minimize potential dangers of certain methods of 
ingestion to consumers (Daniulaityte et al., 2015; Gourdet et al., 2017; Schauer et al., 
2016). 
Summary 
Utilizing and elaborating on the social-cognitive/contextual developmental 
models proposed by Mayes and Suchman (2006) for the developmental paths into 
substance use and dependence, this cross-sectional study sought understand the influence 
of contextual factors and methods of marijuana ingestion within these two models. The 
current study sought to evaluate whether methods of marijuana ingestion were associated 




as mental health outcomes. Furthermore, this study sought evaluate if marijuana users 
endorsed distinct reasons (e.g. safety, price, different type of high) for their primary 
method of ingestion. This study sought to understand if availability of methods 
influenced the primary method of ingestion chosen by participants. Finally, this study 
sought understand if certain methods of ingestion were associated with chronic and 
escalating patterns of marijuana, both of which are associated with increased negative 
short- and long-term outcomes. 
Research in this area continues to be imperative as states proceed with the 
legalization of marijuana for medical as well as recreational. The number of marijuana 
users have steady increased over the last few years for those aged 12 and older 
(Substance Abuse and Mental Health Services Administration, 2018; Substance Abuse 
and Mental Health Services Administration, 2019). This increase in the percentage of the 
population using marijuana, makes it imperative to have a thorough understanding of 
methods of ingestion as they become increasingly diversified and accessible. The current 
study becomes increasingly important to help further research on marijuana as well as 
any potential negative outcomes that can arise from marijuana use as well as continued 
legalization. Research of this nature can be used to create and inform prevention and 
intervention programs for youth as well as young adults to mitigate the potential negative 








Participants and Procedures 
The current study sought to understand the effects of method of ingestion as well 
as contextual factors on marijuana use and associated problems (e.g. frequency of use, 
problematic use, mental health). In addition, this study sought to understand endorsed 
reasons for preferring certain methods of ingestion among individuals. Participants 
included community members recruited primarily through Amazon Mechanical Turk 
(MTurk), as has been done in prior studies (e.g., Daniulaityte et al., 2017). MTurk is a 
crowdsourcing marketplace where individuals and businesses can virtually distribute 
tasks (e.g., data validation, survey participation, and content moderation) to a global 
workforce. Individuals who complete the tasks are called ‘workers’ on the MTurk 
platform (Amazon, 2018). 
For the current study, a survey created in Qualtrics was placed in a task on MTurk 
for participants to complete. Within the MTurk platform, a task was created with the title 
of the dissertation and a short description: “We are currently recruiting community 
members ages 18-25 to participate in a research study on marijuana use and methods of 
ingestion. The goal of this study is to learn more about how you are using marijuana.” 
Keywords were chosen to help participants search for the task, including marijuana, 
weed, pot, dope, grass, reefer, herb, Mary Jane, concentrates, dabs, edibles, joints, blunts, 




To be eligible for the study, potential participants needed to be ages 18-25 and 
report using marijuana within the last month. Individuals who self-reported meeting the 
eligibility criteria clicked the Qualtrics survey link included in the task description on 
MTurk. After completing informed consent online, participants completed a series of 
measures through Qualtrics. At the end of the Qualtrics survey a code was provided for 
the participant to manually enter in the MTurk task to show that the participant 
successfully completed the task. This researcher then reviewed each task to ensure the 
correct code (provided at the end of the survey) was inputted by the participant in MTurk. 
Next the researcher approved the participant to be paid through MTurk. Participants were 
allotted two hours to complete the survey, starting when they clicked on the link in 
MTurk.  
Participation was completely voluntary, anonymous, and compensated ($2.50) 
based on MTurk guidelines. Data were collected from 6/10/19 – 6/20/19. Participants 
included individuals from states with and without legal access to medical and/or 
recreational marijuana. Both female and male participants were recruited, and 
participation was not limited to certain racial or ethnic groups.  
G*Power was used to calculate the necessary sample size to achieve statistical 
power for this study. Cohen (1992) recommends using a power of .80 to determine 
necessary sample sizes to reduce error. With this power, the sample size necessary to 
achieve statistical significance in this study was 196 participants. The power calculation 
was based on the most complex statistical analysis included in this study, ensuring the 




Measures (see Appendix) 
Demographics 
Age, sex, race/ethnicity, highest level of education, annual family income and 
education level, employment status, sexual orientation, relationship status, history of 
family drug use, and current living situation were assessed.  
Daily Sessions, Frequency, Age of Onset, 
And Quantity of Cannabis Use  
Inventory (DFAQ-CU) 
Participants were asked to self-report on marijuana use in their lifetime and within 
the past month using a modified version of the DFAQ-CU. The DFAQ-CU is a 41-item 
survey that measures frequency, age of onset, and quantity of marijuana used. The 
measure has a Cronbach’s alpha ranging from .69 (daily sessions) to .95 (frequency). 
Internal consistency of the quantity, age of onset, and concentrate factors were .88, .81, 
and .76 respectively (Cuttler & Spradlin, 2017). Evidence has been provided for the 
convergent, predictive, and discriminant validity of the factors included in this measure 
with similar surveys (e.g. Marijuana Smoking History Questionnaire, Cannabis Abuse 
Screening Test, Cannabis Use Problems Identification Test; Cuttler & Spradlin, 2017). 
Rutgers Marijuana Problem Index (RMPI) 
Participants completed the RMPI (White, Labouvie, & Papadaratsakis, 2005), 
which consists of 23 items and assesses negative consequences associated with marijuana 
use within the last year. Items on this scale are rated from 0 to 3 (“none” to “more than 5 
times”) based on the frequency of each consequence for the participant. Sample items 
include “Kept smoking when you promised yourself not to” and “Neglected your 




.85 at age 30 (White et al., 2005). In addition to the RMPI being validated through 
research, past literature has shown negative consequences of use to be a distinct measure 
of problem use as well as indicators of substance use problems (White, 1987; White & 
Labouvie, 1989). Scores on all items were added for a total score. 
Comprehensive Marijuana Motives  
Measure (CMMM) 
The CMMM (Lee et al., 2009) measured motives for using marijuana. This scale 
assesses a wide-range of reasons for using marijuana. The original scale includes 12 
subscales (Enjoyment, Conformity, Coping, Experimentation, Boredom, Alcohol, 
Celebration, Altered Perceptions, Social Anxiety, Relative Low Risk, Sleep, and 
Availability) rated on a 1 to 5 scale (“almost never/never” to “almost always/always”). 
The CMMM was revised to include an additional subscale, the Social subscale from the 
Marijuana Motives Measure (Simons, Correia, Carey, & Borsari, 1998), as has been done 
in other past studies (Phillips et al., 2017). The CMMM has internal consistency ranging 
from .78 (availability) to .89 (enjoyment, coping) across all subscales. Cronbach’s alpha 
for the remaining subscales are as follows: .80 for relative low risk, .83 for altered 
perceptions, .84 for alcohol, conformity, sleep, .87 for celebration, and .88 for boredom, 
experimentation, social anxiety (Lee et al., 2009). The CMMM has been validated 
through research comparing it with another 25-item marijuana motives questionnaire 
(Simons, Correia, & Carey, 2000). Scores for all items on each subscale were totaled for 
subscale scores. 
General Mental Health Outcomes 
The eight-item Patient Health Questionnaire Depression Scale (PHQ-8; Kroenke 




Spitzer, Kroenke, Williams, & Löwe, 2006) were used as measures for mental health. 
The PHQ-8 asks participants to rate the number of days in the past two weeks they 
experienced a particular depressive symptom. The PHQ-8 has an internal consistency of 
.86, with a score of >10 having an 88% sensitivity and 88% specificity for major 
depression (Kroenke & Spitzer, 2002). The GAD-7 asks participants to rate the number 
of days in the past two weeks they experienced a particular symptom of anxiety. The 
GAD-7 has an internal consistency of .92 (Spitzer et al., 2006), with a score of having an 
89% sensitivity and 82% specificity. For both questionnaires the response options range 
from 0 to 3 (“not at all” to “nearly every day”). Scores on all items for both measures 
were added for a total score. 
Patterns and Transitions in Marijuana  
Use 
Developed for use in this study, past marijuana use patterns were assessed by a 
series of questions focusing on frequency, quantity, and dose (if known) of marijuana use 
during the past five years. This was assessed by creating a table where participants were 
able to indicate the frequency and quantity of marijuana used during the years following 
age of onset, as well as when they started using at their current level of use. Additionally, 
participants were asked if they changed methods during the years following onset. If 
participants changed methods, they were asked to write in the reason for changing their 
method of marijuana ingestion. 
Contextual Factors 
To assess availability of different methods of marijuana ingestion questions were 
developed for this study including: what is your current state of residence, how easy is it 




easy is it for you to obtain these materials or devices to use marijuana where you 
currently live. Two of these questions involved a rating of ease of obtaining specific 
methods of ingestion (“very easy,” “moderately easy,” “neither easy nor difficult,” 
moderately difficult,” and “very difficult”). The remaining questions asked the source 
where the participant purchased/obtained marijuana (e.g. friend, dispensary, dealer, etc.), 
as well as the current U.S. state of residence of the participant. 
Reasons for Primary Method of  
Marijuana Ingestion 
The Reasons for Primary Method of Marijuana Ingestion comprises multiple 
questions that assess the top reason users endorse for their primary method of ingestion, 
as well as additional reasons. These questions were developed for this study based on 
previous research that has measured reasons related to specific methods of ingestion 
(Giombi et al., 2018; Lee et al., 2016; Loflin & Earleywine, 2014). Participants were 
asked to endorse reasons for their primary method of ingestion as well as methods they 
use more than 25% of the time. 
Statistical Procedures 
Data were analyzed using SPSS statistical software. A total of 350 participants 
completed the online consent. Participants who did not consent (n = 2) nor complete the 
survey (n = 49), displayed unusual response patterns (i.e. answering every question the 
same; n = 25), or self-reported being older than the study criteria when asked to input 
age, were excluded from the analyses (n = 15). 
A total of 261 participants were included in the ensuing statistical analyses. 
Because participants were required to answer every question (i.e., no option was given to 




were conducted to assess whether those who were excluded from the final sample (e.g. 
did not complete the questionnaire) differed on key variables from those who were 
included. There was a significant difference in mean age between included (23.60) and 
excluded (24.38) participants (t121.519 = -3.264, p = .05), which can be explained by the 15 
participants who indicated they were within the eligibility age requirements but went on 
to report ages outside of the eligibility requirements when asked to manually input age. 
Included and excluded participants differed significantly with ethnicity X2 (5, N = 350) = 
41.888, p = .000), with the excluded participants being less than expected numbers for 
ethnicities of Caucasian, African American, and Asian. There was no significant 
difference between included and excluded participants regarding gender (X2 (2, N = 350) 
= 3.680, p = .159). There was a significant difference in highest level of education 
between included and excluded participants, with excluded participants having lower 
levels of education (i.e. less than 12th grade, GED, high school diploma, and some 
college) than expected compared with the included participants (X2 (6, N = 350) = 
32.934, p = .000). Frequency of marijuana use over the last 30 days was not significantly 
different between participants included (13.45) and excluded (13.60) from the analyses 
(t126.320 = .905, p = .776). 
Responses to questions on marijuana use frequency, age of onset, and total years 
of use that were deemed outliers were Winsorized (Fuller, 1991) to the highest or lowest 
reasonable value, determined by the natural cutoffs in the sample and researcher 
judgment of a realistic maximum value. Responses for marijuana frequency over the last 
30 days that were higher than 30 days were decreased to 30. Four participants reported 




to 9 as it was a natural cut off in the sample. Finally, years of total use were corrected by 
subtracting current age from age of first use for participants who reported total years of 
use larger than what would be expected given the ages they self-reported. Descriptive 
statistics were reported for the entire sample. Mean days of marijuana use in the past 30 
days, age of onset, and lifetime use were calculated. Frequencies for primary method of 
ingestion were calculated for the entire sample. See Table 4 for a summary of the 
variables that were derived from each measure included in this study. For all 
demographic variables and marijuana use statistics, all 261 participants were included. A 
low incidence of dab users (n =4) were found in the sample and when examining their 
marijuana use frequency, they were deemed as outliers and excluded from the remaining 
analyses, except for the descriptive analyses in RQ4 and RQ6.  
Table 4 
 
Variables derived from each measure included in the current study 
Measure Variables 
DFAQ-CU Frequency of use, primary method of ingestion, 
secondary methods of ingestion, source of marijuana 
RMPI Problematic use 





Trajectory classes, frequency and quantity of use over 
last 5 years, method of ingestion used for last 5 years, 
transitions in method of ingestion over last 5 years, 
reasons for transition in method of ingestion 
Contextual Factors State of residence, perceived ease of access 
Reasons for 
Primary Method of 
Ingestion 






Q1 Are certain methods of marijuana ingestion related to higher frequency of 
use and problematic use? 
 
The analysis for Research Question One focused on the relationship between 
method of marijuana ingestion, frequency of use over the last 30 days, and problematic 
use. Dependent variables were the number of days used over the last 30 days and 
problematic use. Problematic use was calculated using the total sums from the RMPI. 
The independent variable for this question was method of marijuana ingestion, which 
included three levels: smoking, vaping, and oral. A one-way MANCOVA statistical 
analysis was used to understand these relationships. Covariates for this analysis were 
gender, age, race, and level of education. The first four assumptions for this MANCOVA 
analysis were met as there are two continuous dependent variables, a categorical 
independent variable, at least one continuous covariate, and independent observations. 
Additionally, there was a linear relationship between the dependent variables of number 
of days used over the last 30 days and problematic use as assessed by visual inspection of 
a scatterplot utilizing a loess line fit percentage of 90%. 
Q2 Are certain methods of ingestion related to specific motives for use? 
 
The analysis for Research Question Two focused on the relationship between 
method of ingestion and motives for marijuana use. The dependent variable was 
marijuana motives scales of enjoyment, conformity, coping, experimentation, altered 
perceptions, and availability, with the independent variable being methods of marijuana 
ingestion, which included three levels. A one-way MANCOVA statistical analysis was 
used to understand this relationship. Covariates for this analysis were gender, age, race, 




The first four assumptions for this MANCOVA analysis were met as there are two 
continuous dependent variables, a categorical independent variable, at least one 
continuous covariate, and independent observations. Additionally, there was a linear 
relationship between the dependent variables of motives scales for marijuana use of 
enjoyment, conformity, coping, experimentation, altered perceptions, and availability as 
assessed by visual inspection of a scatterplot utilizing a loess line fit percentage of 90%. 
Q3 Are certain methods of ingestion associated with negative mental health 
outcomes? 
 
The analysis for Research Question Three focused on the relationship between 
method of ingestion and mental health outcomes. Dependent variables were mental health 
outcomes (i.e., depression [PHQ-8] and anxiety [GAD-7]). The independent variable was 
methods of marijuana ingestion, which included three levels. A one-way MANCOVA 
statistical analysis was used to understand these relationships. Covariates for this analysis 
were gender, age, race, level of education, frequency of marijuana use over the last 30 
days, and problematic use. The first four assumptions for this MANCOVA analysis were 
met as there are two continuous dependent variables, a categorical independent variable, 
at least one continuous covariate, and independent observations. Additionally, there was a 
linear relationship between the dependent variables of depression (PHQ-8) and anxiety 
(GAD-7) as assessed by visual inspection of a scatterplot utilizing a loess line fit 
percentage of 90%. 
Q4 Are certain methods of ingestion related to historical and current patterns 
of use in terms of frequency and transitions in methods over the last five 
years to current use? 
 
The Research Question Four analysis consisted of multiple steps. First, individual 




linear growth curve model (Shek & Ma, 2011). This determined individual growth curves 
(IGC) of use over time based on frequency of marijuana use. This growth measurement 
variable was then used in a two-step cluster analysis, due to the size of the data set, to 
determine clusters or classes of individuals with similar growth (e.g. escalating, 
decreasing). A Fisher’s Exact test statistical analysis was then used to analyze the 
relationship between trajectory/class membership and current method of marijuana 
ingestion. Assumptions for this Fisher’s Exact test were met as this analysis comprised of 
two variables measured at the categorical level with independent observations and 
collected using cross-sectional sampling. Regarding transitions between methods, 
descriptive/visual analysis is reported to understand the relationship between endorsed 
transition reason and method of marijuana ingestion across the five years measured. 
Additionally, similar analyses used to derive the trajectory groups were used to create 
classes for transitions in method of ingestion (e.g., no change in method, switching of 
method). A Chi-square statistical analysis was used to analyze the relationship between 
trajectory class and transition of method of ingestion class. Assumptions for this Chi-
square test of independence were met as this analysis comprised of two variables that 
were measured at the categorical level with independence of observations. Data were 
collected using cross-sectional sampling and more than 80% of the cells had counts 
greater than or equal to five. 
Q5 Are primary methods of ingestion influenced by availability or awareness 
of methods? 
 
The analysis for Research Question Five was composed of multiple steps. First, 
participants were grouped by states into three categories: 1) legal marijuana for 




for medical purposes (n = 35 states, n = 155 participants), 3) illegal marijuana for any 
purpose (n = 4 states, n = 30 participants). This variable was used in a Chi-Square 
analysis along with method of ingestion to assess their relationship. Assumptions for this 
Chi-square test of independence were met as this analysis comprised of two variables that 
were measured at the categorical level with independence of observations. Data were 
collected using cross-sectional sampling and more than 80% of the cells had counts 
greater than or equal to five. A Fisher’s Exact test analysis was completed with the source 
of marijuana (e.g. friend, dispensary, dealer) and legal status groupings. Assumptions for 
this Fisher’s Exact test were met as this analysis comprised of two variables measured at 
the categorical level with independent observations and data collected using cross-
sectional sampling. Finally, a series of ordinal logistical regressions were used to 
determine the ease of accessibility for method of ingestion by state legality grouping. In 
this analysis the independent variable was state legality grouping, which included three 
levels, with the dependent variable being the perceived ease of access for each method of 
ingestion. Covariates for this analysis were age, gender, race, and level of education. 
Assumptions for this series of ordinal logistical regressions were met as the dependent 
variables were ordinal, the independent variable is categorical, there was no 
multicollinearity due to just having one independent variable, and the assumption of 
proportional odds was met for each analysis as assessed by a full likelihood ratio test. 
Q6 Are endorsed reasons (e.g. safety, type of high, price) for using certain 
methods different across methods of marijuana ingestion? 
 
Finally, the analyses for Research Question Six consisted of a Chi-Square analysis 
and descriptive/visual analysis. This Chi-square analysis comprised of two variables that 




were collected using cross-sectional sampling, meaning three assumptions for the Chi-
square analysis were met. This Chi-square analysis did not meet the assumption of more 
than 80% of the cells had counts greater than or equal to five. Therefore, a Chi-Square 
analysis utilizing the Monte Carlo sampling method (Mehta & Patel, 2011), due to sparse 
(many cells with less than five) and unbalanced data, was used with primary method of 
ingestion and endorsed reasons as the variables. Next, descriptive statistics were reported 
with methods of ingestion used 25% of the time or more and endorsed reasons as the 
variables. The following figure outlines the research questions proposed in the current 
study and their relationship with method of ingestion. 
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Demographics and Marijuana Use Statistics 
Demographic variables of participants included (n = 261) from the analysis are 
displayed in Table 5. On average participants took 25 minutes to complete the survey. 
Participants were from the United States, per eligibility requirements. Participants were 
located in 39 states and Washington D.C. States with the highest percent of participants 
were: California (n = 36, 14%), Florida (n = 20, 7.8%), Indiana (n = 24, 9.3%), New 
York (n = 14, 5.4%), and Texas (n = 41, 16%). According to current census data, the 
percentage of females in this study (73.3%) is higher than U.S. census data of 50.8%. 
Annual household income is lower than the recorded income from the U.S. census data 
($60,293). Finally, ethnicity in this sample is different from the ethnic background of 
persons completing the U.S. census, with fewer White (U.S. census = 76.5%), fewer 
Black (U.S. census = 13.4%), more American Indian/Alaska Native (U.S. census = 
1.3%), more Asian (U.S. census = 5.9%), fewer Hispanic/Latino (U.S. census = 18.3%), 
and more Biracial/Multiracial (U.S. census = 2.7%) participants (United States, 2020). 
Compared to previous studies on marijuana users (i.e., Loflin & Earleywine, 2014; 
Phillips et al., 2017) this sample differed regarding percentages of females, but not 
regarding ethnicities, except for studies looking at developmental trajectories where 
differences in gender and ethnicity were present (i.e., Brook et al., 2016; Flory et al., 




days, with a mean of 13.47 (SD = 9.67) days used in the last 30 (Range = 1-30). 





Table 5  
Demographic and background characteristics (n =261) 
Measure/variable n (%) Mean (Range) Median 
Age  23.6 (18-25)  
Gender    
     Female 192 (73.3)   
     Male 66 (25.2)   
     Prefer not to respond 3 (1.1)   
Sexual Orientation    
     Gay Male 6 (2.3)   
     Lesbian 4 (1.5)   
     Bisexual 62 (23.8)   
     Heterosexual 186 (71.3)   
     Asexual 1 (.4)   
     Prefer not to respond 2 (.8)   
Relationship Status    
     Single 168 (64.1)   
     Married/Civil Union/Living 
Together Long-Term 
51 (19.5)   
     Seriously Dating/Exclusive 
Relationship 
39 (14.9)   
     Separated/Divorced 3 (1.1)   
Annual Household Income   $30,000 - 40,000 
Current Living Situation    
     Living Alone 115 (44.1)   
     Living with Others 115 (44.1)   
     Living in University 
Housing 
15 (5.7)   
     Living in Residential 
Facility 
7 (2.7)   
     Staying with Relative or 
Friend 
8 (3.1)   
     Staying in a Shelter or 
Homeless 
1 (.4)   
Race/Ethnicity    
     Caucasian 143 (54.8)   
     Hispanic/Latino 13 (5)   
     Black  22 (8.4)   
     Native American / Alaskan 
Native 
15 (17)   





Table 5, continued 
Measure/variable n (%) Mean (Range) Median 
     Biracial/Multiracial 23 (8.8)   
Highest Level of Education    
     GED 1 (.4)   
     High School Diploma 26 (10)   
     Some College 60 (23)   
     Bachelor’s Degree 146 (55.9)   
     Advanced Graduate 
Degree 
27 (10.3)   
     Don’t Know 1 (.4)   
Employment Status    
     Employed Full Time 191 (72.9)   
     Employed Part Time 38 (14.5)   
     Unemployed 12 (4.6)   
     In School Part Time 3 (1.1)   
     In School Full Time 9 (3.4)   
     Working Part Time, 
School Full Time 
2 (.8)   
     Working Full Time, 
School Full Time 
2 (.8)   
     Working Part Time 
and Full Time 
3 (1.1)   
     Working Part 
Time/Full Time, in 
School Part Time 
 
1 (.4)   
Familial Drug Use    
     No One 115   
     Father 108   
     Mother 32   
     Brother 42   
     Sister 18   
     Other 5   
 
Most participants described smoking (using a joint, blunt, hand pipe, hookah, or 
bong) as their primary method of ingestion (n = 187, 71.6%). For 24 participants this was 
their only method of ingestion, however, 238 participants reported using additional 
methods of marijuana ingestion more than 25% of the time including smoking (n = 291; 




25% of the time or more. Additional method of ingestion statistics are included in Table 
6. It is important to note that the majority of participants who reported using additional 
methods of marijuana ingestion 25% of the time reported using multiple methods.  
One hundred and ninety-seven (75.2%) of the participants reported their primary 
form used as marijuana (e.g. flower, bud, herb). Edibles were reported as the primary 
form of marijuana for 45 (17.2%) participants, with concentrates being used by 19 
(7.3%). Two hundred-thirteen participants also reported using other methods over 25% of 
the time, see Table 6. A small number of participants reported ever having a medical 
marijuana registry card (n = 57), with many (36 out of 57) reporting using marijuana 
recreationally and medically. The majority of participants purchased their marijuana from 
a friend (n = 87, 33.3%), followed by a dealer (n = 73, 28%), retail store (n = 55, 21.1%), 
medical dispensary (n = 26, 10%), given for free (n = 17, 6.5%), or grown by the 
participant (n = 3, 1.1%). Additional marijuana use statistics are included in Table 6. See 
Table 7 for statistics regarding participants included in independent variables excluding 






Marijuana use statistics (n =261) 
Measure/variable n (%) Mean (Range) 
Frequency   
     Multiple times per day 30 (11.5)  
     Once per day 17 (6.5)  
     5-6 times per week 15 (5.7)  
     3-4 times per week 28 (10.7)  
     2 times per week 37 (14.2)  
     2-3 times per month 42 (16.1)  
     1-2 times per month 67 (24.7)  
Age of onset  17.66 (9-25) 
Total years of use  5.23 (1-15) 
Age of monthly use  19.07 (9-25) 
Age of daily use  19.29 (9-25) 
Primary method of ingestion   
     Smoking   
         Joint 66 (25.3)  
         Blunts 17 (6.5)  
         Hand pipe 51 (19.5)  
         Bong 35 (13.4)  
         Hookah 18 (6.9)  
     Vaping   
         Vaporizer 28 (10.7)  
         E-cigarette device 24 (9.2)  
     Oral*   
         Edibles* 18 (6.9)*  
     Dabbing   
         Dab rig 4 (1.5)  
Secondary methods of ingestion   
     Smoking   
         Joints 94 (39.5)  
         Blunts 50 (21)  
         Hand pipe 68 (28.6)  
         Bong 41 (17.2)  
         Hookah 38 (16)  
     Vaping   
         Vaporizer 30 (12.6)  





Table 6, continued 
 
Measure/variable n (%) Mean (Range) 
      Oral   
         Edibles 41 (17.2)  
     Dabbing   
         Dab rig 9 (3.8)  
     Topical   
         Topicals 3 (1.3)  
     Other   
          CBD oil 1 (.4)  
Primary form of marijuana used    
     Marijuana 197 (75.2)  
     Edibles 45 (17.2)  
     Concentrates 19 (7.3)  
Secondary forms used   
     Marijuana 135 (63.4)  
     Edibles* 72 (33.8)*  
     Concentrates 50 (23.5)  




Statistics for participants included in independent variables for subsequent analyses, 
excluding dabbers (n =257) 
Measure/variable n (%)  
Grouping by method of ingestion   
     Smoking 187 (72.7)  
     Vaping 52 (20.2)  
     Oral 18 (7)  
Trajectory class   
     Heavy  17 (6.6)  
     Escalating  97 (37.7)  
     Moderate  101 (39.3)  
     Low 42 (16.3)  
Transition in methods   
     No to low transition 186 (72.4)  
     Multiple transitions 71 (27.6)  
Groupings by state legality   
     Illegal  30 (11.7)  
     Recreational and medicinal laws 72 (28)  





Analysis One: Problematic Use and Frequency of Use 
A one-way MANCOVA analysis sought to answer the question of whether certain 
methods of marijuana ingestion, due to immediate effects and potential higher potency, 
are related to increase in frequency of use and problematic use. Dependent variables for 
this analysis were the number of days used over the last 30 days and problematic use 
(calculated from the RMPI). The independent variable for this analysis was method of 
marijuana ingestion (3 levels =smoking, vaping, and oral), with covariates of gender, age, 
race, and level of education. There was no statistically significant difference between 
methods of ingestion groups on the combined dependent variables after controlling for 
gender, age, race, and level of education, F(4, 496) = 1.077, p = .367, Wilks' Λ = .983. 
Because this analysis was not significant, no follow up analyses were conducted. 
Analysis Two: Marijuana Use Motives 
A one-way MANCOVA analysis was used to answer the question of certain 
methods of ingestion being related to specific motives (e.g. coping) for use due to higher 
potency and immediate effects. The dependent variable for this analysis was certain 
marijuana motives, derived from the subscales of the CMMM, with the independent 
variable being methods of marijuana ingestion (3 levels = smoking, vaping, and oral). 
Subscales included in this analysis were enjoyment, conformity, coping, experimentation, 
altered perceptions, and availability. There was no statistically significant difference 
between methods of ingestion groups on the combined dependent variables after 
controlling for gender, age, race, level of education, frequency of marijuana use over the 
last 30 days, and problematic use, F(12, 484) = .879, p = .521, Wilks' Λ = .958. Because 




Analysis Three: Mental Health 
This one-way MANCOVA analysis sought to answer the question if certain 
methods of marijuana ingestion are associated with negative mental health outcomes, 
derived from the GAD-7 and PHQ-8. Dependent variables for this analysis were mental 
health outcomes (i.e., PHQ-8 or depression and GAD-7 or anxiety). The independent 
variable was methods of ingestion (3 levels = smoking, vaping, and oral), with covariates 
of gender, age, race, level of education, frequency of marijuana use over the last 30 days, 
and problematic use. There was no statistically significant difference between methods of 
ingestion groups on the combined dependent variables after controlling for gender, age, 
race, level of education, frequency of marijuana use over the last 30 days, and 
problematic use F(4, 492) = .759, p = .245, Wilks' Λ = .988. Since this analysis was not 
significant, no follow up analyses were conducted. 
Analysis Four: Marijuana Use Trajectories and Transitions 
Analyses for this research question sought to understand patterns of use over the 
last five years in terms of frequency of use, in addition to transitions in method of 
ingestion to see if heavy/chronic and escalating marijuana use patterns are related to 
methods in ingestion with immediate effects and potential higher potency. For this 
analysis, the frequency of use variable was recoded to collapse similar frequency use 
groups (i.e., 0 = no use, 1 = few times per year, 2 = few times per month, 3 = 1-4 times 
per week, 4 = 5 times per week to more than once per day). First, individual changes in 
use over time in frequency of use, in addition to transitions in method of ingestion were 
measured by using a linear growth curve model to determine individual growth curves 




determine classes of individuals with similar growth patterns over time. Three cluster 
analyses were performed to ensure the classes were the best fit for the data regarding 
frequency of use. In the first two-step cluster analysis, clusters were determined 
automatically, which led to a cluster quality falling within the good range, and a ratio of 
sizes of 2.58. The subsequent two-step cluster analyses were conducted with specified 
numbers of clusters of three and five, which resulted in cluster qualities falling within the 
poor ranges. As the cluster analysis with four groups led to the best quality, four use 
trajectories were chosen. Similarly, the same two-step cluster analysis process was used 
to determine clusters for transitions in method of ingestion, which resulted in two classes 
automatically determined. The cluster quality for this analysis fell within the good range, 
with a ratio of sizes of 2.54. Additional analyses with specified clusters of one and three 
resulted in cluster qualities falling within the poor range. For both final cluster analyses 
(i.e. frequency of use and transitions) these groups were assigned numerical values that 
were used to examine the growth variables across the separate groups throughout the five 
years measured. Visual analysis via a scatterplot was used to understand how the groups 
differed across the five years measured (e.g. increasing frequency use, maintaining). 
Through this, the nature of the groups was discovered (e.g. escalators, heavy users, no 







Classes for use trajectory and transition in methods 
Measure/variable n (%) 
Trajectory Class  
     Heavy 46 (17.9) 
     Escalating 103 (40.1) 
     Moderate 68 (26.5) 
     Low 40 (15.6) 
Transition in Methods  
     No to Low Transition 186 (72.4) 
     Multiple Transitions 71 (27.6) 
 
After these classes were established, a Fisher’s Exact test analysis was conducted 
to further understand the relationship between method of ingestion and trajectory class. A 
Chi-square test of independence analysis was conducted to understand the relationship 
between transition in methods and trajectory class. Descriptive analyses are reported for 
endorsed transition reason and method of ingestion.  
A Fisher’s Exact test analysis was completed to examine the relationship between 
method of ingestion and trajectory class. The relationship between method of ingestion 
and trajectory class was not significant X2 (6, N = 257) = 6.597, p = .352, see Table 9 for 
results. 
Table 9 
Results for Fisher’s Exact test analysis for analysis four 
Current Method 
of Ingestion 
Trajectory Class  
Low Moderate Escalating Heavy Total 
Smoking 27 55 72 33 187 
Vaping 9 9 26 8 52 
Oral 4 4 5 5 18 
Total 40 68 103 46 257 
 
A Chi-square test of independence was performed to examine the relationship 




these variables was not significant X2 (3, N = 257) = 1.905, p = .592, see Table 10 for 
results. 
Table 10 
Results for Chi-square analysis for analysis four 
Transition in Method 
of Ingestion 
  Trajectory Class 
Low Moderate Escalating Heavy Total 
No to Low Transition 29 46 79 32 186 
Multiple Transitions 11 22 24 14 71 
Total 40 68 103 46 257 
 
Due to low frequencies, transition in method of ingestion across the five years 
measured are reported descriptively to see if there were specific reasons depending on the 
method of ingestion for transitioning. In this analysis, participants responded to each 
transition in method of ingestion they had over the course of the five years measured, 
with many participants having multiple transitions. Regarding smoking, higher 
frequencies of participants reported “fewer “hits” are necessary” (n =28), “safer to use” 
(n =26), “effects last longer” (n =22), and “different kind of high” (n =21) as their reason 
for transitioning to a smoking method of ingestion, see Figure 6 for additional reasons. 
For vaping, higher frequencies of participants reported “friends use/recommended the 
method” (n =14) and “fewer “hits” are necessary” (n =9) as their reason for transitioning 
to a vaping method of ingestion, see Figure 7 for additional reasons. Regarding dabbing, 
higher frequencies of participants reported “friends use/recommended the method” (n =4) 
and “fewer “hits” are necessary” (n =4) as their reason for transitioning to a dabbing 
method of ingestion. For oral methods of ingestion, higher frequencies of participants 
reported “effects last longer” (n =3), “safer to use” (n =3), and “less side effects” (n =3) 




longer” (n =1) and “friends use/recommended this method” were reported (n =1). For 









































































































Descriptive results for method of ingestion and reason for transitioning 
Reason for Use  Method of Ingestion 
Smoking Vaping Dabbing Oral Topical 
Different kind of high 21 5 0 1 0 
Stronger intoxication effect 19 1 0 0 0 
Effects last longer 22 6 3 3 1 
Fewer “hits” are necessary 28 9 4 1 0 
Safer to use 26 3 3 3 0 
Less side effects 11 5 2 3 0 
Friends use/recommended this 
method 
14 14 4 1 1 
Family members 
use/recommended this method 
6 6 3 0 0 
Tastes better 8 3 2 0 0 
Is easily accessible 9 4 3 1 0 
Is less expensive 4 0 1 1 0 
Is more discreet 3 0 0 0 0 
 
As a part of the descriptive analysis, types of transitions between methods were 
recorded. Out of the 101 participants who reported any transition in method over the past 
five years, the majority (n = 20) transitioned only within smoking methods of ingestion. 
A number of participants reported alternating between vaping and smoking over the five 
years measured (n = 10). A total of eight participants transitioned from vaping to 
smoking. Seven participants transitioned from both smoking to oral (n = 7) and smoking 
to vaping methods of ingestion (n = 7). Overall, 50 participants transitioned to a different 




ultimately transitioned (started with one method, transitioned to different methods, then 
returned to the original method) to the same method of ingestion they first reported. For 






Descriptive results for types of transitions (n = 101) 
Type of Transitions n 
Overall Different Method of Ingestion  
     Alternating vaping and dabbing 3 
     Alternating vaping and smoking 10 
     Dabbing to smoking 1 
     Dabbing, oral, vaping, smoking, vaping 1 
     Dabbing, smoking, vaping 1 
     Dabbing, smoking, vaping, dabbing, smoking 1 
     Dabbing, vaping, oral, smoking 1 
     Dabbing, vaping, smoking 3 
     Oral, dabbing, vaping, smoking, vaping 1 
     Oral, smoking, vaping 3 
     Smoking to oral 7 
     Smoking to vaping 7 
     Smoking, dabbing, smoking, vaping 1 
     Smoking, oral, vaping 2 
     Smoking, vaping, oral, vaping 1 
     Topical, vaping, smoking 1 
     Vaping to dabbing 3 
     Vaping to oral 1 
     Vaping to smoking 8 
     Vaping, smoking, dabbing, smoking 1 
     Vaping, topical, vaping, oral 1 
Overall Same Method of Ingestion  
     Smoking to different smoking methods 20 
     Smoking, dabbing, smoking 4 
     Smoking, dabbing, vaping, smoking 2 
     Smoking, oral, dabbing, smoking 1 
     Smoking, oral, smoking 1 
     Smoking, vaping, dabbing, smoking 2 
     Smoking, vaping, smoking 3 
     Smoking, vaping, smoking, topical, smoking 1 
     Vaping, dabbing, smoking, vaping 1 
     Vaping, dabbing, vaping 2 
     Vaping, oral, vaping 1 
     Vaping to different vaping method 3 
     Vaping, smoking, dabbing, vaping 1 





Analysis Five: Contextual Factors 
These analyses sought to answer the question if primary methods of ingestion are 
influenced by availability or perceived ease of access for certain methods of ingestion, 
with the notion that certain methods of ingestion may be more accessible for individuals, 
leading to these methods by default being primary methods of ingestion. This question 
was answered with multiple analyses including a Chi-square test of independence, 
Fisher’s Exact test, and a series of ordinal logistical regression analyses. Frequencies of 
participants by state legality grouping are included in Table 13.  
Table 13 
Grouping by state legality 
Measure/variable n (%) 
Illegal 30 (11.7) 
Recreational Laws 72 (28) 
Medical Laws 155 (60.3) 
 
A Chi-square test of independence was performed to examine the relationship 
between method of ingestion and state legality. The relationship between these variables 
was not significant X2 (4, N = 257) = 7.220, p = .125, see Table 14 for results. To 
examine the relationship between source of marijuana and state legality a Fisher’s Exact 
test was performed. The relationship between these variables was significant X2 (10, N = 
257) = 45.602, p < .001, and the association was moderately strong (Cohen, 1988) 
(Cramer’s V = .298). For participants in states where marijuana is recreationally legal, 
more participants purchased marijuana from retail stores/dispensaries than expected if 
legal status was independent of source of marijuana, with an adjusted standardized 
residual of 6.3. Additionally, in recreationally legal states fewer participants than 




independent of source of marijuana, with adjusted standardized residuals of -3.0 and -2.5, 
respectively. In states where marijuana was medicinally legal, fewer participants 
purchased marijuana from retail stores/dispensaries than expected if legal status was 
independent of source of marijuana, with an adjusted standardized residual of -4.8. More 
participants than expected in states where marijuana was medicinally legal purchased 
from a dealer if legal status was independent of source, with an adjusted standardized 
residual of 2.9 (Agresti, 2013). Of note, three participants purchased from a medical 
dispensary by crossing state lines. The participants who purchased from a medical 
dispensary were located in states bordering those with medicinal marijuana laws, see 
Table 15 for results. 
Table 14 
Results for first Chi-square analysis for analysis five 
Current Method of 
Ingestion 






Smoking 49 116 22 187 
Vaping 14 31 7 52 
Oral 10 7 1 18 






Results for Fisher’s Exact test analysis for analysis five 
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Total 73 154 30 257 
Note. Adjusted residuals appear in parentheses below observed frequencies. 
A series of ordinal logistical regression analyses sought to understand if certain 
methods of ingestion are associated with differing perceived ease of access based on the 
legal status of marijuana. The dependent variable for this set of analyses was perceived 
ease of access that differed by method of ingestion (i.e., joints, blunts, hand pipes, bongs 
[water pipe], hookahs, vaporizers, e-cigarette devices, dab rigs, edibles, and topicals). All 
analyses had an independent variable of state legality grouping (i.e., recreationally legal, 
medicinally legal, illegal) with covariates of gender, age, race, and level of education. For 
joints, blunts, hand pipes, hookah, and e-cigarette devices state legality grouping did not 




Table 16 for statistical results. Regarding bongs, state legality grouping did have a 
statistically significant effect, with a higher level of education (i.e., GED to advanced 
graduate degree) leading to a 1.409 increase in perceived difficulty. For vaporizers, there 
was a significant effect, with a higher level of education leading to an increase in 
perceived difficulty of 1.509. Finally, regarding dab rigs, edibles, and topicals, state 
legality grouping did have a statistically significant effect with ethnicity significantly 
contributing to the model. Specifically, being not Caucasian was associated with 
increased perceived difficulties of 1.214, 1.138, and 1.156 for dab rigs, edibles, and 





Statistical results for ordinal regression analyses 
Method of 
ingestion 
df Wald p Odds 
Ratio 
CI (95%) IV/Covariate 
Joints 2 2.428 .297    
Blunts 2 1.635 .442    
Hand pipes 2 2.769 .250    
Bongs 2 9.597 .008*    
 1 5.763 .016* 2.597 1.191 - 5.661 Illegal 
 1 8.148 .004** 2.129 1.267 - 3.576 Medicinally legal 
 1 5.572 .018* 1.409 1.060 - 1.874 Level of education 
Hookah 2 5.524 .063    
Vaporizers 2 9.160 .010*    
 1 7.873 .005** 3.037 1.398 - 6.598 Illegal 
 1 5.323 .021* 1.827 1.095 - 3.049 Medicinally legal 
 1 8.068 .005** 1.509 1.136 - 2.005 Level of Education 
 1 22.830 .001*** 1.278 1.156 - 1.414 Ethnicity 
E-cigarette 
devices 
2 4.619 .099    
Dab rigs 2 13.189 .001***    
 1 4.297 .038* 2.254 1.045 - 4.861 Illegal 
 1 12.966 .001*** 2.561 1.535 - 4.272 Medicinally legal 
 1 14.646 .001*** 1.214 1.099 - 1.321 Ethnicity 
Edibles 2 20.488 .001***    
 1 9.283 .002** 3.334 1.536 - 7.233 Illegal 
 1 19.226 .001*** 3.191 1.900 - 5.361 Medicinally legal 
 1 6.685 .010* 1.138 1.031 - 1.255 Ethnicity 
Topicals 2 17.832 .001***    
 1 7.672 .006** 2.972 1.375 - 6.422 Illegal 
 1 16.911 .001*** 2.943 1.759 - 4.922 Medicinally legal 
 1 8.449 .004** 1.156 1.048 - 1.275 Ethnicity 
Note. *p <.05; ** p < 01; *** p <.001 
Analysis Six: Reasons for Use 
A Chi-square test of independence, utilizing Monte Carlo sampling due to sparse 




performed to examine the relationship between method of ingestion and reason for use, 
with the assumption that users endorse distinct reasons for each method of ingestion. The 
relationship between these variables was significant X2 (24, N = 257) = 63.258, p < .001, 
based on 10,000 random samples from this data set, using a starting seed of 624,387,341, 
see Table 17 for results. The association was moderately strong Cramer’s V = .351 
(Cohen, 1988). Regarding smoking, more participants reported is “easily accessible” as 
their reason for use than expected if reason for use was independent of method of 
ingestion, with an adjusted standardized residual of 3.2. Fewer participants reported 
“recommended by family members” and “is more discrete” as smoking reasons for use 
than expected if reason for use was independent of method of ingestion, with adjusted 
standardized residuals of -3.1 and -4.5 respectively. More participants reported “safer to 
use”, “recommended by family members”, and “is more discreet” as vaping reasons for 
use than expected, if method of ingestion was independent of reasons for use, with 
adjusted standardized residuals of 1.9, 3.9, and 3.4, respectively. For vaping, fewer 
participants than expected reported “effects last longer” and “is easily accessible” as 
reasons for use if reasons for use was independent of method of ingestion, with adjusted 
standardized residuals of -1.7 and -2.4 respectively. Regarding oral, more participants 
reported “effects last longer” and “is more discreet” than expected, if reason for use was 
independent of method of ingestion, with adjusted standardized residuals of 1.8 and 2.5 
respectively. Fewer participants than expected reported “is easily accessible” for oral 
methods of ingestion if reasons for use was independent of method of ingestion, with an 






Results for Chi-square analysis for analysis six 
Reason for Use Method of Ingestion 
Smoking Vaping Oral Total 











































































































Total 187 52 18 257 




Descriptive statistics were reported for each method of ingestion used 25% or 
more of the time, due to having low frequencies across many different cells. For 
smoking, more participants reported reasons for use of “stronger intoxication effect” (n = 
43), “effects last longer” (n =46), and “is easily accessible” (n =37). More participants 
reported certain reasons for using vaping as a method of ingestion including “stronger 
intoxication effect” (n =9) and “safer to use” (n =9). For oral, more participants reported 
reasons for use of “different kind of high” (n =8) and “effects last longer” (n =13). 
Regarding dabbing, two participants reported a reason of use of “stronger intoxication 
effect.” For topicals, two participants reported their reason of use was due to topicals 
being “easily accessible.” A summary of these descriptive statistics can be found in Table 
18. Additional reasons described by participants for using smoking, vaping, and oral 






Descriptive results of reason for use for methods of ingestion used 25% or more of the 
time 
Reason for Use Method of Ingestion 
Smoking Vaping Dabbing Oral Topical 
Different kind of high 22 3 1 8 0 
Stronger intoxication effect 43 9 2 6 0 
Effects last longer 46 1 1 13 0 
Fewer “hits” are necessary 32 7 1 1 0 
Safer to use 35 9 1 1 0 
Less side effects 17 5 0 2 0 
Friends use/recommended this 
method 
25 7 1 1 1 
Family members 
use/recommended this method 
6 5 0 1 0 
Tastes better 10 1 0 6 0 
Is easily accessible 37 3 0 1 2 
Is less expensive 4 1 1 0 0 
Is more discreet 6 7 0 1 0 
Other 9 1 0 0 0 






Additional reasons reported by participants for using certain methods of ingestion 
Method of Ingestion/Reason 
Smoking 
     Able to just light it once and smoke casually 
     Because I enjoy the act of smoking and it’s great to share when you smoke 
with friends! 
     Convenience 
     Enjoy the experience of rolling and smoking 
     Easy to share with friends, long lasting, and when you’re in the mood for a 
change, the taste is nice 
     It’s fast 
     Easiest and quickest 
     I enjoy smoking and it is easy to sit on a joint and smoke it for 10-15 
minutes as a source of engagement and to get high 
     Is comfortable 
     It’s comfortable and convenient 
     Joint [sic] get you just as high if not higher than blunts and take less weed 
     Social with friends 
Vaping 
     It’s weak 
Oral 
     I don’t need to keep smoking anything I just take on edible and I’m good for 
a couple of hours 









 This cross-sectional exploratory study aimed to examine current trends and 
associated problems related to marijuana ingestion among young adult marijuana users. 
Research questions addressed by this study included understanding the relationship 
between methods of marijuana ingestion and higher frequency of use, problematic use, 
motives for use, and mental health outcomes. It was hypothesized that methods of 
ingestion that were more potent or with immediate effects, would lead to increases in 
frequency of use, problematic use, negative mental health outcomes, and coping motives 
for use due to the stronger and immediate intoxication effects. Additionally, the current 
study sought to understand the relationship of methods of marijuana ingestion on 
historical and current patterns of use in terms of quantity and transitions in methods over 
the last five years. Methods of ingestion that were more potent with immediate effects 
were hypothesized to be related to heavy/chronic and escalating marijuana use 
trajectories. These same marijuana use trajectories were hypothesized to be related to 
multiple transitions in method of ingestion over the five years measured in this study. 
Contextual factors including availability and awareness of methods were examined. It 
was hypothesized that primary method of ingestion may be influenced by perceived ease 
of access. Furthermore, endorsed reasons for using certain methods of ingestion were 
investigated to understand differences across methods of marijuana ingestion. It was 




related to endorsed reasons regarding the intoxication effect, while oral methods of 
ingestion would be related to discrete or better tasting endorsed reasons for use. 
Two hundred sixty-one (100%) of the participants in this study reported using 
marijuana in the last 30 days, per eligibility requirements. Sixty-two (23.7%) participants 
reported using marijuana on a daily or near daily basis, which is lower than the 
proportion (35.4%) of heavy past-month users reported by the National Academies of 
Science, Engineering, and Medicine (2017). The mean age of onset for the current sample 
was 17.66, which is similar to the age of onset (between 18 to 19 years) found across 
multiple countries (Degenhardt et al., 2008). Participants in the current study endorsed a 
variety of primary methods of ingestion as well as primary forms of marijuana ingested. 
The variety in method of ingestion and marijuana forms used may be partially influenced 
by marijuana dispensaries or retail stores that are increasing the variety of products 
available to consumers (Borodovsky et al., 2016; Pacula et al., 2014; Pacula et al., 2015), 
as 88.5% of the participants in this study lived in a state where marijuana was medically 
or recreationally legal. 
In this study neither problematic use nor frequency of use were found to be 
significantly related to method of ingestion after controlling for gender, age, race, and 
level of education. The lack of relationship between method of ingestion and frequency 
may be related to the fact that previous research has found that method of ingestion, in 
combination with dose or potency, influence marijuana’s subjective effects (Budney & 
Borodovsky, 2017). Because some methods have faster effects, individuals may be able 
to use less frequently and still achieve the same effects one might achieve with higher 




marijuana on a daily or near daily basis, which is lower than what has been previously 
found (35.4%; National Academies of Science, Engineering, and Medicine, 2017). This 
lower than expected frequency (as evidenced by a moderate negative skewness) could 
have influenced the effect of frequency of use over the last 30 days in this study, as well 
as ultimately problematic use, due to higher frequency of use being related to increased 
problematic use, although variability in days used was high. Furthermore, the current 
study had lower portions of participants that endorsed using more potent methods of 
ingestion (i.e., dabbing). These lower numbers could have impacted the effect of 
problematic use, as emerging research is finding concentrates are related to problematic 
use (e.g. Meier, 2017). If the current sample had included a greater number of persons 
who dabbed as their primary method of use, some effect related to frequency and 
problematic use could have been observed. Knowing if method of ingestion is related to 
problematic use can be used to influence regulatory processes in states to determine how 
products can be created, distributed, and accessed, which can influence progressions to 
problematic use and potentially mitigate negative outcomes (Budney & Borodovsky, 
2017). Additionally, information regarding methods of ingestion and their effect on 
problematic use can be utilized in prevention and intervention programs across all ages, 
to continue to tailor and improve them. This can decrease the negative effects these 
methods could have by starting prevention programs and educating youth about possible 
increased negative effects associated with certain methods of ingestion. 
Participants in the current study reported a variety of motives for using marijuana, 
however, method of ingestion was not significantly related to these motives (i.e. 




after controlling for gender, age, race, level of education, frequency of use over the last 
30 days, and problematic use. The current study utilized motives that are often found to 
be related to marijuana use in past studies and sought to understand if method of 
ingestion was related to specific motives for using marijuana. Past research has focused 
mostly on delineating the motives, how motives vary both between and within 
individuals, and motives’ relationship to frequency of use as well as problematic use; 
however, no past research has sought to understand the relationship between motives and 
methods of ingestion (Bonn-Miller et al., 2007). Past research has found that enjoyment, 
altered perception, and conformity motives were associated with increased frequency of 
marijuana use (Bonn-Miller et al., 2007; Davis et al., 2018; Lee et al., 2009). 
Furthermore, coping motives have been shown to be related to problem marijuana use 
(Phillips et al., 2017). Method of ingestion has the potential to be related to motives for 
use as individuals’ motives can differ depending on the method (e.g. smoking as a more 
social method versus vaping for altered perception due to a stronger intoxication effect). 
The current study offers preliminary evidence that method of ingestion is not related to 
motives generally; however, it is unclear whether participants might change their method 
of ingestion within-the-moment based on fluctuating motives. This finding is important 
as past studies have shown certain motives for marijuana use are related to increased risk 
across many psychosocial factors. It is critical to continue to delineate how motives for 
marijuana use vary both between and within individuals. 
Method of ingestion was not significantly related to mental health outcomes, after 
controlling for gender, age, race, level of education, frequency of use over the last 30 




associated with increased risk of anxiety, depression, and lower satisfaction with life, the 
literature is mixed (Brook et al., 2013; Fergusson & Boden, 2008; Patton et al., 2002) and 
many studies do not adequately control for confounding variables (Moore et al., 2007). 
However, the current study sought to understand if method of ingestion could be a 
variable that increases risk for depression and anxiety above and beyond marijuana use 
itself, due to certain high potency forms of marijuana being associated with particular 
methods of ingestion (e.g., dabbing). Unfortunately, persons using the most potent 
method (i.e., dabbing) were not recruited adequately for the study, making it difficult to 
answer this question. Due to the variability of THC levels across different methods of 
ingestion, it is possible that methods with higher intoxication effects can have a greater 
effect on mental health. Additional research is needed to understand the complicated 
relationship between marijuana use and mental health outcomes. Understanding the 
relationship between marijuana use and mental health is important due to the increasingly 
positive attitudes towards marijuana in the United States (Gallup, 2017) and the rise of 
legalization of marijuana for medicinal and recreational purposes. 
 The current study sought to understand the relationship between of method of 
ingestion and historic marijuana use frequency trajectories. Research regarding marijuana 
use trajectories is important to understand factors related to long-term marijuana use, and 
to help identify individuals who will phase out of substance use versus those who escalate 
to regular and heavy use. The current study found four trajectories of use based on 
frequency, which is commensurate with previous research that has historically found 
between three and seven developmental trajectory patterns of marijuana use (e.g. Homel 




2004). Specifically, the current study found trajectory classes that were similar to those 
found by Passarotti and colleagues (2015). They found trajectory classes of never/non-
users (33%), low users (29%), medium users (24%), high users (8%), and escalating 
users (17%). While this study did not include any non-users of marijuana, the remaining 
trajectory classes are similar. The current study found comparable numbers with 
moderate (26.5%) and low users (15.6%); however, it was found that more participants 
classified as escalating (40.1%) and heavy users (17.9%). Heavy users in the current 
study comprised of participants who used daily or more than once per day across the five 
years measured. Moderate and low users included participants who used a few times per 
month and a few times per year, respectively. Regarding escalators, these participants 
reported no or infrequent use at the beginning of the five years measured and transitioned 
to daily or more than once per day use near the end. The higher numbers of participants 
classified as escalating users is potentially related to average age of onset of the sample 
(ages 18 to 25) being 17.66. Many users were answering questions related to use after 
initiating use, with many having increases in frequency of use over the last five years as 
indicated by the high percentage of participants who were escalators. After deriving the 
classes, additional analyses did not indicate significant relationships between trajectory 
class and method of marijuana ingestion nor trajectory class and switching of method of 
ingestion over the last five years. These findings are important as risk factors for chronic, 
heavy, and escalating users need to be understood in the continually changing legal 
climate of marijuana in the United States. Individuals who fall within a higher-use 
trajectory experience increased negative short- and long- term outcomes associated with 




and its relationship with developmental use trajectories is needed to increase 
understanding of negative consequences related to marijuana use and for public health 
planning (Tucker et al., 2005). Through this public health planning, prevention and 
intervention strategies can be targeted to youth who show higher numbers of risk factors 
(e.g., gender, peer influence, parental education, delinquency, emotional dysregulation) 
that can affect the marijuana use trajectory they may fall with-in. Knowledge of these 
specific factors can allow for more targeted interventions for smaller groups of youth, 
while still providing general prevention and intervention strategies for all youth possibly, 
leading to a greater impact of the prevention and intervention strategies. 
Contextual factors including availability or awareness of methods were evaluated 
by the current study. No significant relationship between method of ingestion and state 
legality of marijuana was found. This lack of relationship could be related to a variety of 
methods of ingestion already being available to marijuana users. However, state legality 
was significantly related to the source of marijuana (e.g. purchased from retail store, 
dealer, friend, etc.). This indicates that state legality is related to the source of where 
marijuana is purchased, although many participants reported purchasing from informal 
sources, even in states with medical and recreational marijuana laws. These findings are 
important as they offer preliminary evidence of the relationship between legal status of 
marijuana and its effect on purchasing outcomes. Higher numbers of retail outlets 
available to purchase marijuana can lead to higher availability of varieties of methods of 
ingestion and types of marijuana through lowering travel time and cost of transportation 
(Budney & Borodovsky, 2017). The current study supports the idea that more retail 




affects where the marijuana is purchased. Previous research has found dispensaries per 
square mile to be cross-sectionally associated with increases in marijuana hospitalizations 
with a marijuana abuse/dependence code (Mair et al., 2015). Higher availability of 
methods of ingestion and types of marijuana has the potential to make it easier for youth 
to access marijuana. Interestingly, the current study found more than expected 
participants in states where marijuana is illegal purchased products from medical 
dispensaries. This indicates that consumers are potentially crossing state lines to purchase 
products. Due to the participants not listing the states that the marijuana was purchased, it 
is difficult to say if the states allow access of medical marijuana for out-of-state residents. 
The crossing of state lines to purchase from a retail outlet, ultimately can be viewed as a 
safer, but illegal—especially if out-of-state purchases are not legal, alternative to 
purchasing from an informal source as retail outlets have regulations for products. As 
previously mentioned regarding long-term effects of marijuana use, 16% of e-cigarette, 
or vaping, product use-associated lung injury (EVALI) patients reported acquiring 
products from retail outlets, while 78% acquired them from informal sources (e.g., 
family, friends, dealers; Centers for Disease Control and Prevention, 2020). The current 
study found in states with only medicinal laws (not recreational), more participants (n = 
121) purchased or were given marijuana from informal sources than retail outlets (n = 
31). While there may be retail outlets that provide safer products, due to regulations, 
many individuals are still purchasing marijuana from informal sources that do not have 





The current study found some significant relationships between methods of 
marijuana ingestion and perceived ease of access. In states where marijuana was illegal or 
only medicinally legal, participants reported higher odds of perceived difficulty accessing 
bongs, vaporizers, dab rigs, edibles, and topicals. The current study supports the idea that 
increased retail outlets can influence perceived availability as well as diversity of 
methods of ingestion and products (Budney & Borodovsky, 2017). Odds of perceiving 
difficulty in obtaining dab rigs was slightly lower for participants in states where 
marijuana is illegal compared to medicinally legal. Additionally, as education level 
increased, participants were more likely to report difficulty in finding certain methods of 
ingestion. Regarding ethnicity, Caucasian participants had a lower perceived difficulty in 
obtaining certain methods of ingestion than participants from other ethnicities. This 
finding could in part, be related to differences in portions of participants from varying 
ethnic backgrounds across state legality grouping (e.g. more Caucasian in states with 
recreational marijuana laws). Another potential influence for this finding could be related 
to participants located in rural versus urban areas, with rural participants from varying 
ethnic backgrounds  requiring increased travel times to access different methods of 
ingestion. Continued research in availability and ease of access are needed as the 
prevalence of marijuana outlets as well as information across media forms (e.g. social 
media, radio) continues to increase. Research has found online posts regarding certain 
methods of ingestion (e.g. edibles, dabs) to be positive in nature, normalizing marijuana 
use, and higher in frequency in states that allow recreational use of marijuana (Cavazos-
Rehg et al., 2018; Daniulaityte et al., 2015; Lamy et al., 2016; Lamy et al., 2018). As 




availability and awareness of different methods of ingestion is needed to identify 
emerging trends due to changing marijuana legalization policies, to inform timely 
prevention and policy measures, and minimize potential dangers of certain methods of 
use to consumers (Daniulaityte et al., 2015; Gourdet et al., 2017; Schauer et al., 2016). 
Using emerging trends to inform prevention strategies and policy measures can affect 
youth’s awareness of the potential dangers of certain methods (e.g. concentrates being 
related to problematic use). 
The current study sought to understand reasons for transitioning methods of 
ingestion as well as reasons for using certain methods of ingestion. It was found that the 
relationship between primary method of ingestion and reason for use was significant, 
meaning that participants were endorsing specific reasons for using certain methods. This 
echoes previous research that has found individuals endorse specific reasons for liking 
certain methods of ingestion. These findings have been important as they have 
highlighted specific reasons for using that are associated with potency and stronger 
intoxication effect of certain methods (Loflin & Earleywine, 2014). Similarly, the current 
study found that “stronger intoxication effect,” “fewer “hits” necessary,” and “effects last 
longer” were common reasons reported across most methods endorsed in this study. For 
participants who endorsed using smoking methods of ingestion, common reasons for use 
were “stronger intoxication effect,” “effects last longer,” “fewer “hits” necessary,” 
“different kind of high,” and “is easily accessible.” Participants who used vaping methods 
of ingestion endorsed reasons for use related to “safer to use,” “less side effects,” “family 
members use/recommended it,” “is more discreet,” “stronger intoxication effect,” and 




reasons for use including “effects last longer,” “different kind of high,” “more discreet,” 
“stronger intoxication effect,” and “less side effects.” Findings of this nature suggest that 
endorsed reasons for using certain methods could be a factor related to a higher risk for 
developing substance use disorders due to reasons being related to stronger intoxication 
effects. Interestingly, participants endorsed “safer to use” and “less side effects” as 
reasons for using vaping methods of ingestion. This contradicts emerging research from 
the CDC (2020) indicating that vaping is related to acute lung distress, particularly when 
cartridges are bought from informal sources, although vaping is still considered a safer 
alternative to smoking due to lower levels of carcinogens. Research is still emerging on 
long-term effects of vaping. Continued research, with large sample sizes is needed in this 
area to delineate if individuals endorse specific reasons for transitioning between 
methods or using certain methods. Additionally, continued research in endorsed reason 
for using certain methods of ingestion is important as methods with more positive 
perceptions may influence patterns of use in the United States (Lee et al., 2016). 
Currently, research is extremely limited in this area and future work needs to continue to 
focus on delineating endorsed reasons for using certain methods of ingestion, as well as 
how these reasons vary between methods of ingestion and individuals. This research can 
be used to guide regulatory processes in states to determine how products can be created, 
distributed, and accessed to ensure safety in diverse methods of ingestion (Budney & 
Borodovsky, 2017). 
Limitations 
 The current research study has several limitations. First, participants of the current 




non-generalizable results. Compared to U.S. census data the current study should be 
interpreted with caution due to differences in gender and ethnicity; however, compared to 
some previous research in the field of marijuana studies this study was similar in reported 
ethnicities of participants. As the survey was anonymous it was not possible to identify 
repeat respondents. A significant limitation to the current study was the cross-sectional 
nature of the data collected. To understand causal relationships between methods of 
marijuana ingestion and associated problems, longitudinal studies are required that 
measure participants over a range of use (e.g. youth to adulthood). 
 Statistically, limitations of the current study included large differences in the 
numbers of participants for each level of the MANCOVA used, which violates one of the 
assumptions of this statistical procedure and resulted in the removal of dabbing as a 
method of ingestion. Due to the number of methods endorsed by participants as well as 
the number of reasons for using certain methods endorsed, there were analyses that did 
not have sufficient distribution across the cells to be analyzed, leading to some 
information being presented in a descriptive manner in the current study. Continued 
research in reasons for using certain methods is needed, as a broad range of reasons were 
endorsed for each method, including many new reasons that were not included in the 
original development of the measure for the current study. 
Finally, increased numbers of participants are necessary to fully understand 
endorsed reasons for primary method of ingestion as well as transitions in methods due to 
the variety of reasons that are endorsed across individuals. Certain methods that are more 
potent with immediate effects (e.g. dabbing) had low occurrence rates within this sample, 




problems of use (e.g. problematic use, frequency of use). Due to this low frequency, 
participants should have been over-sampled to ensure that this method of ingestion could 
have been included in the analyses. 
Future Directions 
 Future research should continue to delineate associations of methods of marijuana 
ingestion in the continually changing legalization climate in the United States. As 
marijuana is the most commonly used, federally illicit drug, it becomes increasingly 
important to understand factors related to increased marijuana use, as it is associated with 
a plethora of negative outcomes. During the time this dissertation was being drafted, 
marijuana use for those ages 12 and older increased by nearly 20 million individuals in 
one year (Substance Abuse and Mental Health Services Administration, 2018; Substance 
Abuse and Mental Health Services Administration, 2019). Research with higher numbers 
of participants is needed to try and understand methods of ingestion that are being used 
less frequently (e.g. dabs) but have the potential to have increased negative outcomes due 
to potency and immediate effects. It is imperative to continue to identify short- and long-
term effects of products with high potency and immediate effects as research is currently 
lacking.  
 The developmental course of marijuana use should continue to be monitored, with 
increased focus on methods of ingestion as a contextual factor that can affect the 
trajectory. While this study did not find significant results in this area, it was cross 
sectional in nature, which can result in participants who might not have been able to 
accurately report marijuana use information over the past five years as compared to 




continue to be diversified with easier access for younger and younger individuals. This 
can affect the trajectory of use for these individuals. Therefore, it is important to try and 
understand factors related to these negative trajectories as soon as possible, because 
research is lacking behind this ever-changing legalization climate. It is imperative to 
understand negative outcomes to influence safety standards and regulations (Benjamin & 
Fossler, 2016; Cao et al., 2016).  
 In this study, participants endorsed a variety of reasons for using certain methods 
of ingestion, with many participants writing in new reasons not originally included. 
Future research needs to continue to understand these reasons for use, and to understand 
if they are related to any associated problems (e.g. problematic use, negative mental 
health outcomes) for users. This is important research as it can help understand reasons 
why someone may choose a certain method (e.g. safer, stronger intoxication effect), 
because positive perceptions of methods of ingestion that are readily available may 
influence patterns of use (Lee et al., 2016).  
Retail outlets for marijuana are motivated to increase sales through increasing the 
variety of products available to consumers (Borodovsky et al., 2016; Pacula et al., 2014; 
Pacula et al., 2015), however, many products lack empirically-based packaging 
regulations, proactive ingredient levels, and safety standards (Benjamin & Fossler, 2016; 
Cao et al., 2016). The current study found that high numbers of participants were 
obtaining marijuana from informal sources (e.g. friends, family, dealers). It is important 
to continue to understand where marijuana is being purchased as the CDC has found that 
many patients diagnosed with EVALI had purchased marijuana from informal sources 




highlights the importance of empirically based packaging regulation and safety standards. 
Recently, a family was arrested for having more than 30,000 vape cartridges of THC as 
well as nearly 100,000 mason jars filled with THC oil (Salo, 2019, October 2). This 
family is just one example of an informal source of marijuana, with limited to no 
regulation and safety standards. As access to a variety of methods of marijuana ingestion 
continues to grow, a body of evidence is necessary to guide, prioritize, and evaluate 
public health and policy efforts regarding marijuana (Allen et al., 2017). 
Conclusion 
Overall, the current study found that methods of ingestion (e.g. smoking, vaping, 
oral) were not related to problematic use nor frequency of use. Methods of ingestion were 
found to not be significantly related to motives for marijuana use (i.e. enjoyment, 
conformity, coping, experimentation, altered perceptions, and availability). Furthermore, 
this study found that methods of ingestion were not significantly related to mental health 
outcomes (i.e. anxiety and depression). The current study was able to classify participants 
into four trajectory use classes; however, the classes were not significantly related to 
method of ingestion. Additionally, differences in individuals transitioning between 
methods were found, resulting in two transition classes, however these were not 
significantly related to trajectory classes based on frequency of use and quantity. No 
relationship was found between state legality status and current method of ingestion; 
however, state legality status was related to perceived difficulty of obtaining vaporizers, 
dab rigs, edibles, and topicals. Furthermore, it was found that state legality significantly 
affected where marijuana was purchased, with many more participants than expected in 




The current study found that particular reasons for use are endorsed more 
frequently for certain methods. Specifically, for smoking more common reasons for using 
included: “stronger intoxication effect,” “effects last longer,” “fewer “hits” necessary,” 
“different kind of high,” and “is easily accessible.” For vaping methods of ingestion 
participants endorsed reasons of “safer to use,” “less side effects,” “family members 
use/recommended it,” “is more discreet,” “stronger intoxication effect,” and 
“recommended/used by friends.” Finally, for oral methods of ingestion, participants 
endorsed reasons for use including “effects last longer,” “different kind of high,” “more 
discreet,” “stronger intoxication effect,” and “less side effects.” 
In conclusion, while the current study found some preliminary evidence related to 
methods of ingestion, as well as differences in endorsed reasons for use for certain 
methods of ingestion, additional research is needed to establish other factors that may 
relate to methods of ingestion. Methods of ingestion should be considered when 
developing prevention strategies as certain methods could be associated with higher rates 
of negative short- and long-term consequences associated with marijuana use. Methods of 
marijuana ingestion have the potential to influence use, and research is needed to 
understand these possible influences to guide intervention strategies as well as public 
policy. 
As a school psychologist, working within the school system, increased knowledge 
regarding the effect of methods of ingestion and contextual factors with youth can be 
critical in helping schools choose effective prevention and intervention strategies. Some 
strategies that could be useful would be general screening, for all students, that seeks to 




intervention strategies can be tailored to provide youth with information to help increase 
their knowledge of potential dangers to use (e.g. formal versus informal sources of 
marijuana, short- and long- term consequence of use). Additionally, youth who show 
many risk factors related to chronic or heavy use trajectories can receive more specific 
interventions (e.g. small group or individual) tailored to mitigating some of these risk 
factors (e.g. emotional dysregulation, peer influence, college attainment). Schools are 
positioned in a way to influence many youth across the nation, given that the average age 
of onset for this sample was 17.66. Meaning, there are many youth who are initiating use 
before the age of 17 who can be affected by strategies utilized in schools.  
Furthermore, for school psychologists working in other settings (e.g., private 
practice, integrated primary care) the use of screening tools can be equally beneficial. 
While school psychologists in these settings are seeing fewer youth, screening for 
substance use is equally as important. Youth and their families who present to these 
settings are seeking intervention services for their family. It is critical to conduct 
consultation interviews that seek to understand parental as well as youth risk factors, and 
screen for substance use. Collecting all this information is critical to implement targeted 
intervention strategies before the youth’s substance use becomes problematic. Families 
and youth may not report substance use as the reason for seeking services, but it is critical 
to screen for substance use as it has many short- and long-term effects that can be related 
to why a family is presenting for services (e.g. changes in memory, learning, negative 
emotionality, psychotic symptoms). Furthermore, in states where marijuana is legal and 
there are more retail outlets for purchasing, it may be critical to screen all youth who 




age of onset for certain methods of ingestion (Borodovsky et al., 2017). With increasing 
numbers of states legalizing marijuana for medical as well as recreational use, a thorough 
understanding of methods of ingestion is necessary as they are becoming increasingly 
diversified and accessible. This research can identify any potential negative outcomes 
that can arise from legalization of marijuana as well as guide, prioritize, and evaluate 
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Participants will first review a description of the study and informed consent. Following 
this, they will be prompted to indicate their agreement to participate.  
 
Q1 ELECTRONIC CONSENT: Please select your choice below. You may print a copy 
of this consent for your records. Clicking on the “Agree” button indicates that: 
• You have read the above information 
• You voluntarily agree to participate 














Q4 How old are you? 
 
Q5 Which term best describes your ethnicity? 
o Not Hispanic or Latino 
o Hispanic/Latino 
 
Q6 Please indicate your race/ethnicity? (check all that apply) 
o Caucasian / White 
o Black 
o Native American / Alaskan Native 
o Biracial / Multiracial (Please Specify) _____________ 
o Asian 
o Pacific Islander / Native Hawaiian 
o Hispanic / Latino 
o Other (Please Specify) ___________ 
 
Q7 How would you characterize your current relationship/marital status? 
o Single 
o Married / Civil Union/ Living together long term 
o Seriously dating / exclusive relationship with a partner 






Q8 What is your sexual orientation? 
o Gay Male 
o Lesbian 
o Bisexual 
o Heterosexual / Straight 
o Other (Please Specify) ___________ 
o Prefer not to respond 
 
Q9 Would you consider the area you live in to be rural or urban? 
o Rural (<2,500 population) 
o Urban Cluster (2,500-50,000 population) 
o Urban (>50,000 population) 
 
Q10 Which of the following best describes your current living situation? 
o Live alone in my own home (e.g., house, apartment, etc.) 
o Live in a household with other people 
o Live in university housing 
o Live in a residential facility where meals and household help are routinely 
provided by paid staff (or could be if requested) 
o Temporarily staying with a relative or friend 
o Temporarily staying in a shelter or are homeless 
o Other __________ 
 
Q11 Are you currently working? (check all that apply) 
 Yes, full time (35 or more hours per week) 
 Yes, part time (less than 35 hours per week) 
 No, currently unemployed 
 Receiving disability (SSI) 
 In school part-time 
 In school full-time 
 Retired 
 Other: __________ 
 
Q12 Please describe the highest level of education you have attained. 
o Less than 12th grade and No GED 
o GED 
o High school diploma 
o Some College 
o Bachelor’s degree 
o Advanced graduate degree (e.g. Master’s, Law Degree, MD, PhD, etc.) 
o Don’t know 
 
Q13 Please describe the highest level of education attained by your mom. 
o Less than 12th grade and No GED 
o GED 




o Some College 
o Bachelor’s degree 
o Advanced graduate degree (e.g. Master’s, Law Degree, MD, PhD, etc.) 
o Don’t know 
 
Q14 Please describe the highest level of education attained by your dad. 
o Less than 12th grade and No GED 
o GED 
o High school diploma 
o Some College 
o Bachelor’s degree 
o Advanced graduate degree (e.g. Master’s, Law Degree, MD, PhD, etc.) 
o Don’t know 
 
Q15 How would you describe your family’s income when you were a young teen (e.g. 12 
– 15 old)? Please include your best guess based upon all income earned by your mom, 
dad, guardian, etc. for the WHOLE household. Total family income was: 
o Under $20,000 per year 
o Between $20,000--$30,000 per year 
o Between $20,000--$30,000 per year 
o Between $30,000--$40,000 per year 
o Between $40,000--$60,000 per year 
o Between $60,000--$80,000 per year 
o Between $80,000--$100,000 per year 
o Between $100,000--$150,000 per year 
o Between $150,000--$200,000 per year 
o Between $200,000--$250,000 per year 
o Above $250,000 per year 
 
Q16 How would you describe your income currently? 
o Under $20,000 per year 
o Between $20,000--$30,000 per year 
o Between $20,000--$30,000 per year 
o Between $30,000--$40,000 per year 
o Between $40,000--$60,000 per year 
o Between $60,000--$80,000 per year 
o Between $80,000--$100,000 per year 
o Between $100,000--$150,000 per year 
o Between $150,000--$200,000 per year 
o Between $200,000--$250,000 per year 
o Above $250,000 per year 
 
Q17 Did any members of your immediate family abuse drugs or alcohol while you were 







 Brother 1 
 Sister 1 
 Other 1 (write in relation of person): __________ 
 Other 2 (write in relation of person): __________ 
 
Q18 Please rate the severity of drug use by the immediate family members you indicated 
in the previous question? 
 No 
consequences 








went to treatment) 
Severe (experienced many 
negative consequences 
[e.g., went to treatment 
multiple times, had legal 
trouble]) 
Father o  o  o  o  
Mother o  o  o  o  
Brother o  o  o  o  
Sister o  o  o  o  
Other 1 o  o  o  o  






Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory 
(DFAQ) 
 
DFAQ_1 Which of the following best captures when you last used marijuana? 
o 3 weeks ago 
o 2 weeks age 
o Last week 
o This week 
o Yesterday 
o Today 
o I am currently high 
 
DFAQ_1b How high are you right now? 
o I am not high at all 
o I am a little bit high 
o I am moderately high 
o I am very high 
o I am extremely high 
 
DFAQ_2 Which of the following best captures the average frequency you currently use 
marijuana? 
o I do not currently use marijuana 
o Less than once a year 
o Once a year 
o Once every 3 to 6 months (2-4 times per year) 
o Once every 2 months (6 times per year) 
o Once a month 
o 2—3 time a month 
o Once a week 
o Twice a week 
o 3—4 times a week 
o 5—6 times a week 
o Once a day 
o More than once a day 
 
DFAQ_3 Which of the following best captures how long you have been using marijuana 
at this frequency? 
o Less than 1 month 
o 1—3 months 
o 3—6 months 
o 6—9 months 
o 9—12 months 
o 1—2 years 
o 2—3 years 
o 3—5 years 




o 15-20 years 
o More than 20 years 
 
DFAQ_4 Before the period of time you indicated above, how frequency did you use 
marijuana? 
o I did not use marijuana 
o Less than once a year 
o Once every 3 to 6 months (2-4 times per year) 
o Once every 2 months (6 times per year) 
o Once a month 
o 2—3 times a month 
o Once a week 
o Twice a week 
o 3—4 times a week 
o 5—6 times a week 
o Once a day 
o More than once a day 
 
DFAQ_5 How many days of the past week did you use marijuana? 
o 0 days 
o 1 days 
o 2 days 
o 3 days 
o 4 days 
o 5 days 
o 6 days 
o 7 days 
 
DFAQ_6 Approximately how many days (0-30) of the past month did you use 
marijuana? 
 
DFAQ_8 Which of the following best captures your pattern of marijuana use throughout 
the week? 
o I do not use marijuana at all 
o I only use marijuana on weekends 
o I only use marijuana on weekdays 
o I use marijuana on BOTH weekends and weekdays 
 
DFAQ_9 How many hours after waking up do you typically first use marijuana? 
o I do not use marijuana at all 
o 12—18 hours after waking up 
o 9—12 hours after waking up 
o 6—9 hours after waking up 
o 3—6 hours after waking up 
o 1—3 hours after waking up 




o With 1/2 hour of waking up 
o Immediately upon waking up 
 
DFAQ_10 How many times a day, on a typical weekday, do you use marijuana? 
 
DFAQ_11 How many times a day, on a typical weekend, do you use marijuana? 
 
DFAQ_12 What is the primary method you use to ingest marijuana? 
o Joint 
o Blunts (cigar sized joints) 
o Hand pipe 
o Bong (water pipe) 
o Hookah 
o Vaporizer (e.g. Volcano, vape pen) 
o E-cigarette device (sold for nicotine) 
o Dab rig (e.g. oil rig, hot knives) 
o Edibles 
o Topicals (e.g., lotions, creams) 
o Other ___________ 
 
DFAQ_13 Which of the following other methods to ingest marijuana do you use 
regularly (at least 25% of the time you use marijuana)? [Check all that apply] 
 Blunts (cigar sized joints) 
 Hand pipe 
 Bong (water pipe) 
 Hookah 
 Vaporizer (e.g. Volcano, vape pen) 
 E-cigarette device (sold for nicotine) 
 Dab rig (e.g. oil rig, hot knives) 
 Edibles 
 Topicals (e.g., lotions, creams) 
 Other ___________ 
 
DFAQ_14 What is the primary form of marijuana you use? 
o None 
o Marijuana (e.g. Flower, Bud, Herb) 
o Edibles 
o Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil) 
o Other __________ 
 
DFAQ_15 Which other forms of marijuana do you use regularly (at least 25% of the time 
you use marijuana)? [Check all that apply] 
 None 
 Marijuana (e.g. Flower, Bud, Herb) 
 Edibles 




 Other __________ 
 
DFAQ_image Please use the image below to refer to various quantities of marijuana. The 
image is not to scale; the dollar bill is included to help provide size perspective.
 
 
DFAQ_16a In a typical session (e.g., a period devoted to using), how much marijuana 
(e.g., Flower, Bud, Herd) do you personally use? 
o 1/8 gram (0.125) 
o 1/4 gram (0.25) 
o 1/2 gram (0.5) 
o 3/4 gram (0.75) 
o 1.0 gram 
o 1.5 grams 
o 2.0 grams 
o 2.5 grams 
o 3.0 grams 
o 3.5 grams (1/8 ounce) 
o 7 grams (1/4 ounce) 
o Other __________ 
o I don’t know 
 
DFAQ_17a On a typical day when you use marijuana (e.g. Flower, Bud, Herb), how 
much do you personally use?  
o 1/8 gram (0.125) 
o 1/4 gram (0.25) 
o 1/2 gram (0.5) 
o 3/4 gram (0.75) 




o 1.5 grams 
o 2.0 grams 
o 2.5 grams 
o 3.0 grams 
o 3.5 grams (1/8 ounce) 
o 7 grams (1/4 ounce) 
o Other __________ 
o I don’t know 
 
DFAQ_18a How much marijuana (e.g. Flower, Bud, Herb), did you personally use 
yesterday? 
o 1/8 gram (0.125) 
o 1/4 gram (0.25) 
o 1/2 gram (0.5) 
o 3/4 gram (0.75) 
o 1.0 gram 
o 1.5 grams 
o 2.0 grams 
o 2.5 grams 
o 3.0 grams 
o 3.5 grams (1/8 ounce) 
o 7 grams (1/4 ounce) 
o Other __________ 
o I don’t know 
 
DFAQ_19a In a typical week you use marijuana (e.g. Flower, Bud, Herb), how much 
marijuana do you personally use? 
o 1/8 gram (0.125) 
o 1/4 gram (0.25) 
o 1/2 gram (0.5) 
o 3/4 gram (0.75) 
o 1.0 gram 
o 1.5 grams 
o 2.0 grams 
o 2.5 grams 
o 3.0 grams 
o 3.5 grams (1/8 ounce) 
o 7 grams (1/4 ounce) 
o Other __________ 
o I don’t know 
 
DFAQ_20a On a typical day you use marijuana (e.g. Flower, Bud, Herb), how many 
sessions (e.g., a period devoted to using) do you have? 
 
DFAQ_21a What is the average THC content/potency of the marijuana (e.g., Flower 










o Greater than 30% 
o I don’t know 
 
DFAQ_16b In a typical session (e.g., a period devoted to using), when you use marijuana 
concentrates, how many hits do you personally take? 
 
DFAQ_17b On a typical day you use marijuana concentrates, how many hits do you 
personally take? 
 
DFAQ_18b Yesterday, how many hits of marijuana concentrates did you personally 
take? 
 
DFAQ_19b In a typical week you use marijuana concentrates, how many grams do you 
personally use (Please note that a typical concentrate amount = .08 - .10 grams)? 
o .05 grams 
o .08 grams 
o .10 grams 
o .20 grams 
o Other __________ 
o I don’t know 
 
DFAQ_20b On a typical day when you use marijuana concentrates, how many sessions 
(e.g. a period devoted to using) do you have? 
 
DFAQ_21b What is the average THC content/potency of the marijuana (e.g., Flower 










o Greater than 90% 
o I don’t know 
 
DFAQ_21c When you eat edibles, how many milligrams of THC do you personally 




includes 10 milligrams. An example would be one gummy bear, which are usually 10 
milligrams each. 
o 5 milligrams 
o 10 milligrams 
o 15 milligrams 
o 20 milligrams 
o Other __________ 
o I don’t know 
 
DFAQ_21d What type of edible do you typically consume (e.g. cookies, gummy bear, 
etc.)? 
 
DFAQ_24 How old were you when you FIRST tried marijuana (in any form)? 
 
DFAQ_23 How many years in total have you used marijuana? 
 
DFAQ_25 Has there been any time in your life when you used marijuana regularly (2 or 




DFAQ_25b How old were you when you FIRST STARTED using marijuana regularly (2 
or more times per month)? 
 
DFAQ_25c Has there been any time in your life when you used marijuana on a daily or 




DFAQ_25cii How old were you when you FIRST STARTED using marijuana on a daily 
or near daily basis? 
 
DFAQ_26 Which of the following best captures the average frequency that you used 
marijuana before the age of 16? 
o Never 
o Less than once a year 
o Once every 3 to 6 months (2—4 times per year) 
o Once every 2 months (6 times per year) 
o Once a month 
o 2—3 times a month 
o Once a week 
o Twice a week 
o 3—4 times a week 
o 5—6 times a week 
o Once a day 





DFAQ_27 Do you have a prescription to use marijuana for medical purposes? 
o No 
o Yes 
o Yes, but I use it for both medical and recreational purposes 
 
DFAQ_27b Which medical condition(s) do you use marijuana to treat? 
o Pain, please describe: __________ 






o Other, please describe: __________ 
 
DFAQ_27c What percentage of the time do you use marijuana for recreational (rather 
than medical) purposes? 
 
DFAQ_28 Where do you typically get your marijuana?  
o Purchase from retail store/dispensary for those over age 21 (you PERSONALLY 
buy it from a retail store/dispensary) 
o Purchase from medical dispensary (you PERSONALLY have a medical 
marijuana card) 
o Purchase from a dealer 
o Purchase from a friend 
o It’s given to me for free (friend/family) 
o I grow my own 
o Other __________ 
 
DFAQ_29 When you use marijuana, what is the most common strain you use? 
o Indica-dominant 
o Sativa-dominant 
o Hybrid (Indica-dominant) 
o Hybrid (Sativa-dominant) 
o Hybrid (unsure of breakdown) 
o Other __________ 
o Do not know 
 
DFAQ_30 Do you think the questions up to this point have accurately measured your 







DFAQ_30b Please describe in words any aspects of your marijuana use that were not 
reflected well in your answers to these questions. What information about your marijuana 




Rutgers Marijuana Problem Index 
 
RMPI_1 Different things happen to people while they are using marijuana or because of 
their marijuana use. Several of these things are listed below. How many times have the 
following happened to you while you were using marijuana or because of using 
marijuana during the LAST YEAR? 
 Never (0) One or two 
times (1) 
Three to five 
times (2) 
More than five 
times (3) 
Not able to do your 
homework or study for a 
test (1) 
o  o  o  o  
Got into fights with other 
people (friends, relatives, 
strangers) (2) 
o  o  o  o  
Missed out on other things 
because you spend too 
much money on marijuana 
(3) 
o  o  o  o  
Went to work or school 
high from marijuana (4) 
o  o  o  o  
Caused shame or 
embarrassment to 
someone (5) 
o  o  o  o  
Neglected your 
responsibilities (6) 
o  o  o  o  
Relatives avoided you (7) o  o  o  o  
Felt that you needed more 
marijuana than you used 
to in order to get the same 
effect (8) 
o  o  o  o  
Tried to control your 
marijuana use (for 
example, used only at 
certain times of the day or 
in certain places, that is, 
tried to change your 
pattern of use) (9) 
o  o  o  o  
Had withdrawal 
symptoms, that is, felt 
sick because you stopped 
or cut down on your 
marijuana use (10) 
o  o  o  o  
Noticed a change in your 
personality (11) 
o  o  o  o  
Felt you had a problem 
with marijuana (12) 





RMPI_2 How many times have the following happened to you while you were using 
marijuana or because of using marijuana during the LAST YEAR? 
 Never (0) One or two 
times (1) 
Three to five 
times (2) 
More than five 
times (3) 
Missed a day (or part of a 
day) of school or work 
(13) 
o  o  o  o  
Wanted to stop using 
marijuana but couldn’t 
(14) 
o  o  o  o  
Suddenly found yourself 
in a place that you could 
not remember getting to 
(15) 
o  o  o  o  
Passed out of fainted 
suddenly (16) 
o  o  o  o  
Had a fight, argument or 
bad feelings with a friend 
(17) 
o  o  o  o  
Had a fight, argument, or 
bad feelings with a family 
member (18) 
o  o  o  o  
Kept using marijuana 
when you promised 
yourself not to (19) 
o  o  o  o  
Felt you were going crazy 
(20) 
o  o  o  o  
Has a bad time (21) o  o  o  o  
Felt physically or 
psychologically dependent 
on marijuana (22) 
o  o  o  o  
Was told by a friend, 
neighbor or relative to 
stop or cut down on your 
marijuana use (23) 






Comprehensive Marijuana Motives Measure 
 
MMQ_1 Please select the FREQUENCY below for each question to indicate how often 













To enjoy the effects of it 
(1) 
o  o  o  o  o  
Because you felt pressure 
from others who do it (2) 
o  o  o  o  o  
To forget your problems 
(3) 
o  o  o  o  o  
Because you were 
experimenting (4) 
o  o  o  o  o  
Because you had nothing 
better to do (5) 
o  o  o  o  o  
Because you were drunk 
(6) 
o  o  o  o  o  
To celebrate (7) o  o  o  o  o  
Because you want to alter 
your perspective (8) 
o  o  o  o  o  
Because it makes you 
more comfortable in an 
unfamiliar situation (9) 
o  o  o  o  o  
Because it is safer than 
drinking alcohol (10) 
o  o  o  o  o  
To help you sleep (11) o  o  o  o  o  
Because it is readily 
available (12) 
o  o  o  o  o  
Because you would not 
eat without using 
marijuana first (13) 
o  o  o  o  o  
Because it helps you 
enjoy a party (14) 
o  o  o  o  o  
Because it is fun (15) o  o  o  o  o  
Because you didn’t want 
to be the only one not 
doing it (16) 






MMQ_2 Please select the FREQUENCY below for each question to indicate how often 













Because you were 
depressed (17) 
o  o  o  o  o  
Because you were curious 
about marijuana (18) 
o  o  o  o  o  
Because it increases your 
appetite (19) 
o  o  o  o  o  
To be sociable (20) o  o  o  o  o  
To relieve boredom (21) o  o  o  o  o  
Because you were under 
the influence of alcohol 
(22) 
o  o  o  o  o  
Because it was a special 
day (23) 
o  o  o  o  o  
Because you want to alter 
your perspective (24) 
o  o  o  o  o  
To allow you to think 
differently (25) 
o  o  o  o  o  
To make you feel more 
confident (26) 
o  o  o  o  o  
To help you eat regularly 
(27) 
o  o  o  o  o  
Because it is not a 
dangerous drug (28) 
o  o  o  o  o  
Because it helps make 
napping easier and 
enjoyable (29) 
o  o  o  o  o  
Because it helps you 
enjoy food more (30) 
o  o  o  o  o  
Because you can get it for 
free (31) 






MMQ_3 Please select the FREQUENCY below for each question to indicate how often 













To feel good (32) o  o  o  o  o  
To be cool (33) o  o  o  o  o  
Because it makes social 
gathering more fun (34) 
o  o  o  o  o  
To escape from your life 
(35) 
o  o  o  o  o  
To see what it felt like 
(36) 
o  o  o  o  o  
Because you wanted 
something to do (37) 
o  o  o  o  o  
Because it is part of your 
meal routine (38) 
o  o  o  o  o  
Because you had gotten 
drunk and weren’t 
thinking about what you 
were doing (39) 
o  o  o  o  o  
Because it was a special 
occasion (40) 
o  o  o  o  o  
So you can look at the 
world differently (41) 
o  o  o  o  o  
Because it relaxes you 
when you are in an 
insecure situation (42) 
o  o  o  o  o  
Because there are low 
health risks (43) 
o  o  o  o  o  
Because you are having 
problems sleeping (44) 
o  o  o  o  o  






Generalized Anxiety Disorder Scale (GAD-7) 
 
GAD-7 Over the LAST 2 WEEKS, how often have you been bothered by the following 
problems? 
 Not at all Several 
days 
More than 
half the days 
Nearly 
every day 
Feeling nervous, anxious or on 
edge (1) 
o  o  o  o  
Not being able to stop or 
control worrying (2) 
o  o  o  o  
Worrying too much about 
different things (3) 
o  o  o  o  
Trouble relaxing (4) o  o  o  o  
Being so restless that it is hard 
to sit still (5) 
o  o  o  o  
Becoming easily annoyed or 
irritable (6) 
o  o  o  o  
Feeling afraid as if something 
awful might happen (7) 






Patient Health Questionnaire Depression Scale (PHQ-8) 
 
PHQ-8 Over the LAST 2 WEEKS, how often have you been bothered by the following 
problems? 





half the days 
Nearly 
every day 
Little interest or pleasure in 
doing things (1) 
o  o  o  o  
Feeling down, depressed, or 
hopeless (2) 
o  o  o  o  
Trouble falling or staying 
asleep, or sleeping too much (3) 
o  o  o  o  
Feeling tired or having little 
energy (4) 
o  o  o  o  
Poor appetite or overeating (5) o  o  o  o  
Feeling bad about yourself –or 
that you are a failure or have let 
yourself or your family down 
(6) 
o  o  o  o  
Trouble concentrating on 
things, such as reading the 
newspaper or watching 
television (7) 
o  o  o  o  
Moving or speaking so slowly 
that other people could have 
noticed? Or the opposite –being 
so fidgety or restless that you 
have been moving around a lot 
more than usual (8) 






Patterns and Transitions in Marijuana Use 
 
In the next few questions you will be asked about your marijuana use over the last five 
years. For each year you will be asked to estimate the frequency of your use, the amount 
used on a typical day (if you are able to recall), the primary form of marijuana used, the 
primary method of ingestion used, and if your primary method changed from one year to 
the next. If your primary method did not change, select no. If you did not use marijuana 
at all for a specific year, simply choose “did not use this year” as the response for all 
questions. 
 
Trajectories_1 For each of the following questions, please think about the ENTIRE year 
listed on the left when answering each question. 












2018 o  o  o  o  
2017 o  o  o  o  
2016 o  o  o  o  
2015 o  o  o  o  














Why did it 
change? 
2018 o  o  o  o  o  
2017 o  o  o  o  o  
2016 o  o  o  o  o  
2015 o  o  o  o  o  
2014 o  o  o  o  o  
 
Trajectories_2 Response options for State of Residence 
(Select from drop down box of all U.S. states.) 
 
Trajectories_3 Response options for Frequency of use: 
o Did not use this year 
o Less than once a year 
o Once every 3 to 6 months (2—4 times per year) 
o Once every 2 months (6 times per year) 
o Once a month 
o 2—3 times a month 
o Once a week 
o Twice a week 
o 3—4 times a week 




o Once a day 
o More than once a day 
 
Trajectories_4 Response options for Primary form of marijuana used: 
o Did not use this year 
o Marijuana (e.g. Flower, Bud, Herb) 
o Edibles 
o Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil) 
o Other 
 
Trajectories_5 Response options for Additional forms of marijuana used: 
o Did not use this year 
o Marijuana (e.g. Flower, Bud, Herb) 
o Edibles 
o Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil) 
o Other 
 
Trajectories_6 Response options for Amount of marijuana (flower) used on a typical 
day: 
o Did not use this year 
o 1/8 gram (0.125) 
o 1/4 gram (0.25) 
o 1/2 gram (0.5) 
o 3/4 gram (0.75) 
o 1.0 gram 
o 1.5 grams 
o 2.0 grams 
o 2.5 grams 
o 3.0 grams 
o 3.5 grams (1/8 ounce) 
o 7 grams (1/4 ounce) 
o Other __________ 
o I don’t know 
 
Trajectories_7 Response options for Amount of edibles used on a typical day: 
o 5 milligrams 
o 10 milligrams 
o 15 milligrams 
o 20 milligrams 
o Other __________ 
o I don’t know 
 
Trajectories_8 Response options for Amount of concentrates used on a typical day: 
o .05 grams 
o .08 grams 




o .20 grams 
o Other __________ 
o I don’t know 
 
Trajectories_9 Response options for Primary method used: 
o Did not use this year 
o Joint 
o Blunts (cigar sized joints) 
o Hand pipe 
o Bong (water pipe) 
o Hookah 
o Vaporizer (e.g. Volcano, vape pen) 
o E-cigarette device (sold for nicotine) 
o Dab rig (e.g. oil rig, hot knives) 
o Edibles 
o Topicals (e.g., lotions, creams) 
o Other ___________ 
 
Trajectories_10 Response options for Additional methods used: 
o Did not use this year 
o Joint 
o Blunts (cigar sized joints) 
o Hand pipe 
o Bong (water pipe) 
o Hookah 
o Vaporizer (e.g. Volcano, vape pen) 
o E-cigarette device (sold for nicotine) 
o Dab rig (e.g. oil rig, hot knives) 
o Edibles 
o Topicals (e.g., lotions, creams) 
o Other ___________ 
 
Trajectories_11 Did your primary method of ingestion change from the year before 
this? 




Trajectories_12 Response options for Why did method of ingestion change: 
o Did not use this year 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 




o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 






Contextual_1 What is your current state of residence? 
(Select from drop down box of states.) 
 
Contextual_2 How easy is it for you to obtain the following forms of marijuana where 
you currently live?  










Flower, Bud, Herb) 
o  o  o  o  o  
Edibles o  o  o  o  o  
Concentrates (e.g., 
Oil, Wax, Shatter, 
Butane Hash Oil) 
o  o  o  o  o  
 
Contextual_3 How easy is it for you to obtain these materials or devices to use marijuana 












Joint o  o  o  o  o  
Blunts (cigar sized 
joints) 
o  o  o  o  o  
Hand pipe o  o  o  o  o  
Bong (water pipe) o  o  o  o  o  
Hookah o  o  o  o  o  
Vaporizer (e.g., 
Volcano, vape pen) 
o  o  o  o  o  
E-cigarette device (sold 
for nicotine) 
o  o  o  o  o  
Dab rig (e.g. oil rig, hot 
knives) 
o  o  o  o  o  
Edibles o  o  o  o  o  
Topicals (e.g., lotions, 
creams) 





Reasons for Primary Method of Marijuana Ingestion 
 
Reasons_1 Which of the following best captures the top reasons why you use the primary 
method (Joints) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2 Which other reasons capture why you use the primary method (Joints) you 
mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1b Which of the following best captures the top reasons why you use the 
primary method (Blunts) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 





Reasons_2b Which other reasons capture why you use the primary method (Blunts) you 
mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1c Which of the following best captures the top reasons why you use the 
primary method (Hand pipe) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2c Which other reasons capture why you use the primary method (Hand pipe) 
you mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_1d Which of the following best captures the top reasons why you use the 
primary method (Bong) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2d Which other reasons capture why you use the primary method (Bong) you 
mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1e Which of the following best captures the top reasons why you use the 
primary method (Hookah) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 





Reasons_2e Which other reasons capture why you use the primary method (Hookah) you 
mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1f Which of the following best captures the top reasons why you use the 
primary method (Vaporizer or vape pen) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2f Which other reasons capture why you use the primary method (Vaporizer or 
vape pen) you mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_1g Which of the following best captures the top reasons why you use the 
primary method (e-cigarette device; sold for nicotine) you mentioned earlier to ingest 
marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2g Which other reasons capture why you use the primary method (e-cigarette 
device; sold for nicotine) you mentioned earlier to ingest marijuana? [Check all that 
apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1h Which of the following best captures the top reasons why you use the 
primary method (Dab rig; e.g., oil rig, hot knives) you mentioned earlier to ingest 
marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 




o Other _____ 
 
Reasons_2h Which other reasons capture why you use the primary method (Dab rig; e.g., 
oil rig, hot knives) you mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1i Which of the following best captures the top reasons why you use the 
primary method (Edibles) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2i Which other reasons capture why you use the primary method (Edibles) you 
mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_1j Which of the following best captures the top reasons why you use the 
primary method (Topicals; lotions, creams) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_2j Which other reasons capture why you use the primary method (Topicals; 
lotions, creams) you mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_1k Which of the following best captures the top reasons why you use the 
primary method (Other) you mentioned earlier to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 





Reasons_2k Which other reasons capture why you use the primary method (Other) you 
mentioned earlier to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3 Which of the following best captures the top reasons why you use the method 
of Joints 25% of the time to ingest marijuana? 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4 Which other reasons capture why you use the method of Joints 25% of the 
time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_3b Which of the following best captures the top reasons why you use the 
method of Blunts 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4b Which other reasons capture why you use the method of Blunts 25% of the 
time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3c Which of the following best captures the top reasons why you use the 
method of Hand pipe 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 





Reasons_4c Which other reasons capture why you use the method of Hand pipe 25% of 
the time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3d Which of the following best captures the top reasons why you use the 
method of Bong 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4d Which other reasons capture why you use the method of Bong 25% of the 
time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_3e Which of the following best captures the top reasons why you use the 
method of Hookah 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4e Which other reasons capture why you use the method of Hookah 25% of the 
time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3f Which of the following best captures the top reasons why you use the method 
of Vaporizer 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 





Reasons_4f Which other reasons capture why you use the method of Vaporizer 25% of 
the time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3g Which of the following best captures the top reasons why you use the 
method of e-cigarette device (sold for nicotine) 25% of the time to ingest marijuana  
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4g Which other reasons capture why you use the method of e-cigarette device 
(sold for nicotine) 25% of the time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_3h Which of the following best captures the top reasons why you use the 
method of Dab rig (e.g., oil rig, hot knives) 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4h Which other reasons capture why you use the method of Dab rig (e.g., oil 
rig, hot knives) 25% of the time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3i Which of the following best captures the top reasons why you use the method 
of Edibles 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 





Reasons_4i Which other reasons capture why you use the method of Edibles 25% of the 
time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 
 Other _________ 
 
Reasons_3j Which of the following best captures the top reasons why you use the method 
of Topicals (e,g., lotions, creams) 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4j Which other reasons capture why you use the method of Topicals (e.g., 
lotions, creams) 25% of the time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 





Reasons_3k Which of the following best captures the top reasons why you use the 
method of Other 25% of the time to ingest marijuana 
o Different kind of high 
o Stronger intoxication effect 
o Effect last longer 
o Fewer “hits” are necessary 
o Safer to use 
o Less side effects 
o Friends use/recommended this method 
o Family members use/recommended this method 
o Tastes better 
o Is easily accessible 
o Is less expensive 
o Other _________ 
 
Reasons_4k Which other reasons capture why you use the method of Other 25% of the 
time to ingest marijuana? [Check all that apply] 
 Different kind of high 
 Stronger intoxication effect 
 Effect last longer 
 Fewer “hits” are necessary 
 Safer to use 
 Less side effects 
 Friends use/recommended this method 
 Family members use/recommended this method 
 Tastes better 
 Is easily accessible 
 Is less expensive 



























CONSENT FOR HUMAN PARTICIPANTS IN RESEARCH 
UNIVERSITY OF NORTHERN COLORADO 
 
Project Title: Current Trends in Marijuana Methods of Ingestion Among Young Adult 
Marijuana Users 
Researcher: Maryia Schneider, M.A. 
Email: schn8458@bears.unco.edu 
Faculty Researchers: David Hulac, Ph.D. & Kristina Phillips, Ph.D. 
Faculty contact: David.Hulac@unco.edu 
 
Purpose and Description 
 
We are currently recruiting community members over the age of 18 to participate in a 
research study on marijuana use and methods of ingestion. The goal of this study is to 
learn more about how you are using marijuana, both currently and since you first began 
using. 
 
As part of this study, you will be asked to fill out a survey that takes approximately 20-30 
minutes to complete.   
 
Your participation in this survey is voluntary. You may refuse to take part in the research 
or exit the survey at any time without penalty. You will be asked to answer questions 
regarding yourself, your marijuana use over time, and any emotional concerns. Your 
responses will help us learn more about methods of marijuana ingestion.  
 
Some of the questions concern sensitive information about you. Most people do not 
experience any discomfort when answering such questions, but others may find 
answering these questions uncomfortable. There are no foreseeable risks involved in 
participating in this study.  
 
Your responses to the questions will be anonymous. No identifying information about 
your responses will be provided to anyone outside of this study. Information that is 
collected via the survey software program are stored in a single secure data center (not in 
the cloud). We will not ask any information that identifies you (e.g., your name of social 
security number) on the survey link. All paper research records will be kept in a locked 
file; only the researchers will have access to the records. All date will be destroyed three 





While there are no direct benefits from participating in this study, there is an indirect 
benefit of knowing you participated in a study that will support research focused on 
marijuana use. Participants are financially reimbursed for their participation. The 
reimbursement for completing the study will be $2.50 paid through Amazon. 
 
If you have questions at any time about the study or the procedures, you may contact 
Maryia Schneider at schn8458@bears.unco.edu.  
 
Participation is voluntary. You may decide not to participate in this study and if you 
begin participation you may still decide to stop and withdraw at any time. Your decision 
will be respected and will not result in loss of benefits to which you are otherwise 
entitled. Having read the above and having had an opportunity to ask any questions, 
please sign below if you would like to participate in this research. You may print a copy 
of this form to retain for future reference. If you have any concerns about your selection 
or treatment as a research participant, please contact the Office of Research, Kepner Hall, 
University of Northern Colorado Greeley, CO 80639; 970-351-1910.  
 
ELECTRONIC CONSENT: Please select your choice below. You may print a copy of 
this consent form for your records. Clicking on the “Agree” button indicates that 
 
• You have read the above information 
• You voluntarily agree to participate 
• You are 18 years of age or older 
• You currently use marijuana at least monthly 
 
  Agree 
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Purpose and Description 
 
We are currently recruiting community members over the age of 18 to participate in a 
research study on marijuana use and methods of ingestion. The goal of this study is to 
learn more about how you are using marijuana, both currently and since you first began 
using. 
 
As part of this study, you will be asked to fill out a survey that takes approximately 20-30 
minutes to complete.   
 
Your participation in this survey is voluntary. You may refuse to take part in the research 
or exit the survey at any time without penalty. You will be asked to answer questions 
regarding yourself, your marijuana use over time, and any emotional concerns. Your 
responses will help us learn more about methods of marijuana ingestion.  
 
Some of the questions concern sensitive information about you. Most people do not 
experience any discomfort when answering such questions, but others may find 
answering these questions uncomfortable. There are no foreseeable risks involved in 
participating in this study.  
 
Your responses to the questions will be anonymous. No identifying information about 
your responses will be provided to anyone outside of this study. Information that is 
collected via the survey software program are stored in a single secure data center (not in 
the cloud). We will not ask any information that identifies you (e.g., your name of social 
security number) on the survey link. All paper research records will be kept in a locked 
file; only the researchers will have access to the records. All date will be destroyed three 





While there are no direct benefits from participating in this study, there is an indirect 
benefit of knowing you participated in a study that will support research focused on 
marijuana use. Participants are not financially reimbursed for their participation. 
 
If you have questions at any time about the study or the procedures, you may contact 
Maryia Schneider at schn8458@bears.unco.edu.  
 
Participation is voluntary. You may decide not to participate in this study and if you 
begin participation you may still decide to stop and withdraw at any time. Your decision 
will be respected and will not result in loss of benefits to which you are otherwise 
entitled. Having read the above and having had an opportunity to ask any questions, 
please sign below if you would like to participate in this research. You may print a copy 
of this form to retain for future reference. If you have any concerns about your selection 
or treatment as a research participant, please contact the Office of Research, Kepner Hall, 
University of Northern Colorado Greeley, CO 80639; 970-351-1910.  
 
ELECTRONIC CONSENT: Please select your choice below. You may print a copy of 
this consent form for your records. Clicking on the “Agree” button indicates that 
 
• You have read the above information 
• You voluntarily agree to participate 
• You are 18 years of age or older 
• You currently use marijuana at least monthly 
 
  Agree 
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